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Abstract	  Using	   a	   range	   of	   computational	   chemistry	   methods	   including	   Molecular	  Dynamics	   (MD)	   simulations,	   quantum	   mechanical	   (QM)-­‐chemical	   cluster,	   and	  quantum	  mechanics/molecular	  mechanics	   (QM/M)	  methods,	  we	  have	   investigated	  the	   catalytic	  mechanism	  and	   inhibition	  of	   two	  physiologically	   important	   enzymes;	  glucosamine-­‐6-­‐phosphate	  synthase	  and	  CTX-­‐M	  β-­‐lactamase,	  respectively.	  More	  specifically,	   for	  the	  inhibition	  of	  CTX-­‐M	  β-­‐lactamase	  it	  was	  observed	  that	  an	   active	   site	   serinyl	   (Ser130)	   residue	   initially	   assists	   in	   stabilizing	   the	   reactive	  complex.	  The	  side-­‐chain	  hydroxyl	  (β-­‐OH)	  of	  Ser130	  is	  deprotonated	  by	  the	  nearby	  side-­‐chain	  amine	  of	  Lys73.	  This	  enables	   the	   resulting	  now	  oxyanionic	  β-­‐oxygen	   to	  nucleophilically	  attack	  the	  substrate's	  key	  ring	  carbonyl	  carbon	  centre.	  This	  reaction	  step	   occurs	   with	   a	   barrier	   of	   74.5	   kJ	   mol-­‐1	   and	   results	   in	   the	   formation	   of	   a	  covalently	  cross-­‐linked	  enzyme-­‐ligand	  intermediate.	  Interestingly,	  whether	  Lys73	  is	  initially	  in	  its	  protonated	  or	  neutral	  state	  in	  the	  reactive	  complex,	  due	  to	  the	  nearby	  presence	  of	  a	  glutamate	  residue,	  it	  is	  able	  to	  readily	  act	  as	  a	  base	  to	  deprotonate	  the	  side-­‐chain	  hydroxyl	  of	  Ser130.	  For	  glucosamine-­‐6-­‐phosphate	  synthase,	  the	  protonation	  state	  of	  His504	  and	  its	  catalytic	  role	  were	  elucidated.	  The	  mechanism	  for	  opening	  of	  the	  substrate's	  sugar	  ring	  in	  which	  His504	  initially	  acts	  as	  an	  acid	  but	  later	  as	  a	  base,	  occurs	  with	  a	  barrier	  of	  107.2	  kJ	  mol-­‐1.	  An	  alternative	  pathway	  was	  considered	  in	  which	  Glu488	  is	  able	  to	  act	   as	   a	   base	   and	   His504	   as	   an	   acid.	   This	  mechanism	  was	   found	   to	   occur	  with	   a	  lower	  reaction	  barrier	  of	  91.5	  kJ	  mol-­‐1.	  The	  results	  of	  MD	  simulations	  also	  supported	  the	  suggesting	  of	  His504	  being	  protonated	  as	   it	  results	   in	  a	  more	  consistent	  active	  site-­‐bound	   reactive	   complex.	   The	  work	   in	   this	   thesis	   highlight	   the	   significance	   of	  approaching	   enzymatic	   systems	   through	   both	   molecular	   dynamic	   and	   quantum	  mechanical/molecular	  mechanical	  techniques.	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1.1	  Introduction	  Heterocyclic	   ring	   systems	   are	   ubiquitous	   chemical	   features	   found	   across	   the	  spectrum	  of	  biologically	  relevant	  molecules.	  A	  wide	  variety	  of	  synthetic	  and	  natural	  ring-­‐containing	   compounds	   found	   throughout	   biochemistry	   are	   integral	   to	  biochemical	   and	   physiological	   systems.	   The	   well-­‐defined	   geometry	   of	   functional	  groups	  around	  a	  ring	  system	  has	  a	  significant	  impact	  on	  the	  structures	  and	  functions	  of	  the	  biomolecules.	  For	  example	  different	  sugar	  systems	  often	  vary	  by	  only	  a	  single	  atom	  or	  two,	  or	  a	  small	  difference	  in	  geometry,	  which	  can	  have	  substantial	  effects	  on	  their	   physical	   and	   (bio)chemical	   properties.1-­‐3	   Fructose	   and	   glucose	   are	   both	  hexoses,	   having	   the	   formula	   C6H12O,	   but	   fructose	   is	   a	   five-­‐membered	   ring	   sugar	  while	   glucose	   is	   a	   six	  membered	   ring.2	   The	   latter	   has	   a	   lower	   solubility	   in	  water.	  Another	  example	  can	  be	  found	  in	  the	  blood	  cell	  antigens,	  which	  are	  composed	  of	  a	  variety	  of	  sugar	  rings	  (Figure	  1.1).1	  Mixing	  of	   the	  wrong	  blood	   types	  can	   lead	   to	  a	  dangerous	   and	   rapid	   immune	   response,	   arising	   from	   the	   slight	   variance	   in	   sugar	  ring	  systems	  of	  the	  antigens.	  	  
	  
Figure	   1.1.	   Schematic	   representation	  of	   the	   three	  blood	   type	   sugar	   antigens,	  A,	  B	  and	  O.	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Another	   vitally	   important	   class	   of	   ring	   system	   are	   those	   containing	   nitrogen.	  This	   includes	   a	   wide	   spectrum	   of	   biologically	   relevant	   molecules	   such	   as	   nucleic	  acids,	   amino	   acid	   metabolites,	   and	   pharmaceuticals.	   For	   example,	   one	   must	   not	  understate	   the	   significant	   effects	   nicotine,	   a	   nitrogen-­‐containing	   heterocyclic	  compound,	   has	   on	   the	   parasympathetic	   nervous	   system	   of	   the	   human	   body.4	   Of	  course,	  this	  is	  not	  limited	  to	  naturally-­‐occurring	  compounds.	  Synthetic	  compounds,	  such	   as	   barbiturates,	   also	   have	   potent	   effects.5	   These	   are	   central	   nervous	   system	  depressants	   capable	   of	   producing	   anesthetic	   effects	   for	   several	   hours.	  We	   cannot	  underappreciate	  the	  diverse	  capabilities	  of	  ring	  systems	  in	  biological	  systems.	   It	   is	  therefore	   important	   to	   deepen	   our	   understanding	   of	   these	   diverse,	   robust	  compounds	  and	  their	  relation	  to	  enzymatic	  systems.	  	  	  
1.2	  Understanding	  Enzyme	  Catalysis	  	  Enzymes	   are	   remarkable	   biocatalysts	   that	   are	   essential	   for	   life.	   They	   are	  composed	  from	  a	  set	  of	  20	  genetically	  encoded	  amino	  acids,	  some	  of	  which	  may	  be	  post-­‐translationally	   modified,	   linked	   together	   with	   amide	   bonds	   to	   form	  polypeptides.	   Some	   also	   incorporate	   non-­‐protein	   molecules	   such	   as	   cofactors	   or	  metals.	   This	   provides	   them	   with	   a	   great	   diversity	   in	   structure	   and	   chemical	  functionality,	  and	  as	  a	  result	  they	  are	  able	  to	  catalyze	  the	  variety	  of	  physiologically	  important	  reactions	  that	  range	  from	  simple	  proton	  transfers	  to	  the	  hydrolysis	  and	  break-­‐down	  of	   complex	  molecules.6	  Comprehending	  how	   their	   rate	  enhancements	  are	   achieved	   remains	   one	   of	   the	   most	   crucial	   steps	   in	   understanding	   biological	  catalysis.	   It	   is	   important	   to	   explore	   the	   intricacies	   of	   their	   reactions	   to	   exploit	   or	  inhibit	  the	  reactions	  of	  these	  impressive	  biological	  catalysts.7	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Figure	  1.2.	  Reaction	  coordinate	  diagram	  showcasing	  an	  uncatalyzed	  reaction	  (red)	  versus	  an	  enzyme	  catalyzed	  reaction	  (green).	  	   Enzymes	   are	   able	   to	   achieve	   their	   rate	   enhancement	   capabilities	   through	   a	  variety	   of	   different	   chemical	   strategies.8	   The	   major	   contributing	   factor	   is	   the	  lowering	   of	   the	   activation	   energy	   of	   the	   reaction	   through	   the	   stabilization	   of	   the	  high-­‐energy	   transition	   states	   that	   occur	   (Figure	   1.2).9	   A	   variety	   of	   factors	   can	  contribute	  to	  this	  stabilization,	  such	  as	  the	  electrostatic	  environment	  or	  a	  hydrogen	  bonding	  network	  within	  the	  active	  site.10	  Enzymes	  also	  provide	  an	  environment	  for	  proximity.	  The	  active	  site	  exists	  as	  a	  microenvironment	  that	  places	  the	  substrates	  in	  a	  geometry	  that	   is	  extremely	   favourable	   for	   the	  reaction	  to	  occur.9,11	  Other	   factors	  that	   affect	   enzyme	   catalysis	   may	   include	   quantum	   tunneling,	   conformational	  dynamics,	   and	   desolvation.8	   Most	   importantly,	   while	   one	   factor	   may	   contribute	  more	  than	  another,	  it	  is	  often	  a	  combination	  of	  these	  effects	  that	  drive	  the	  process	  of	  catalysis.	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1.3	  Antibiotic	  Resistance	  and	  β-­‐lactamase	  Inhibition	  	  Unfortunately,	   our	   species	   is	   on	   the	   verge	   of	   losing	   some	   of	   our	  most	   recent	  medical	   advancements	   thanks	   to	   the	   rise	  of	   antibiotic	   resistant	  bacteria.12	   Indeed,	  overuse	   of	   common	   antibiotics	   has	   led	   to	   the	   emergence	   of	   bacteria	   capable	   of	  surviving	   our	   strongest	   antibiotics.13	  While	   antibiotic	   resistance	   is	   the	   cumulative	  result	  of	  a	  variety	  of	  systems,	  one	  particular	  culprit	  is	  the	  enzyme	  β-­‐lactamase.14	  	  The	  discovery	  of	  penicillin	  and	  its	  application	  to	  treating	  bacterial	  infections	  has	  had	   a	   monumental	   effect	   on	   human	   and	   animal	   health	   in	   the	   last	   century.	   This	  discovery	   led	   to	   the	   creation	   of	   β-­‐lactam	   antibiotics,	   bicyclic	   nitrogen-­‐containing	  compounds	   (Figure	   1.2).15	   These	   compounds	   directly	   inhibit	   the	   biosynthesis	   of	  peptidoglycan,	  which	   is	   used	   to	  make	   bacterial	   cell	  walls,	   and	   thus	   result	   in	   their	  death.	  Unfortunately,	  some	  bacteria	  contain	  β-­‐lactamase,	  which	  hydrolytically	  opens	  the	   lactam	  ring,	   therefore	  making	   them	   inactive.	  One	  strategy	   to	  prevent	   this	   is	   to	  combine	  antibiotics	  with	  a	  β-­‐lactamase	  inhibitor.15	  Understanding	  how	  β-­‐lactamase	  is	  inhibited	  may	  create	  future	  leads	  for	  inhibitor	  design.	  	  
	  
Figure	  1.2	  Various	  core	  lactam	  ring	  structures;	  A)	  oxacephem,	  B)	  carbacephem,	  C)	  carbapenam,	  D)	  penem,	  and	  E)	  oxapenam.	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1.4	  The	  Synthetic	  Domain	  of	  Glucosamine	  6-­‐P	  Synthase	  	  Glucosamine	  6-­‐phosphate	  synthase	  is	  a	  multi-­‐active	  site	  enzyme	  that	  belongs	  to	  the	   family	   of	   enzymes	   known	   as	   amidotransferases.	   This	   class	   of	   enzymes	   is	  responsible	   for	   deamination	   of	   glutamine	   to	   form	   glutamate	   and	   an	   aminated	  product.16	   In	   glucosamine-­‐6-­‐phosphate	   synthase’s	   case,	   the	   overall	   reaction	  produces	   glucosamine-­‐6-­‐phosphate	   from	   the	   fructose-­‐6-­‐phosphate	   substrate	  (Scheme	  1.1).17	  This	  produces	  glucosamine-­‐6-­‐phosphate,	  a	  crucial	  molecule	  used	  in	  a	  variety	  of	  biologically	  essential	  processes	  across	  a	  spectrum	  of	  organisms.	  	  	  
Scheme	  1.1	  Reaction	  of	  glucosamine-­‐6-­‐phosphate	  synthase.	  	  	  
	  
	   Deamination	   of	   glutamine	   occurs	   in	   the	   deaminase	   site,	   the	   ammonium	   ion	  produced	   then	   travels	   through	   an	   ~18	   Å	   tunnel	   where	   it	   arrives	   at	   the	   synthase	  site.18	  This	  site	  is	  capable	  of	  two	  reactions;	  the	  ring	  opening	  of	  fructose-­‐6-­‐phosphate,	  and	  its	  amination	  to	  glucosamine-­‐6-­‐phosphate.	  Understanding	  the	  catalytic	  reaction	  of	   this	   enzyme	   is	   vital	   as	   its	   product	   has	   implications	   in	   diabetes,	   fungal	   chitin	  production,	  and	  bacteria’s	  cell	  wall	  production.19-­‐21	  	  	  
1.5	  Application	  of	  Computational	  Chemistry	  to	  Enzymatic	  
Processes	  One	  of	  the	  most	  difficult	  challenges	  in	  studying	  enzymatic	  reactions	  arises	  from	  their	  high	  rate	  enhancement.	   It	   is	  extremely	  difficult	   to	  study	   the	  nuances	  of	   their	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behaviour.	   For	   example,	   the	   decarboxylation	   reaction	   of	   orotidine	   5’-­‐phosphate	  takes	  78	  million	  years	  to	  occur,	  but	  with	  the	  help	  of	  the	  decarboxylase	  enzyme	  it	  is	  accomplished	   in	   less	   than	   a	   second.22	   Computational	   chemistry	   can	   allow	   us	   to	  circumvent	   this	   incredible	   speed	  of	   reaction.	   Indeed,	   computational	   chemistry	  has	  been	  shown	  to	  be	  a	  successful	  tool	  in	  studying	  these	  diverse	  catalysts	  by	  identifying	  difficult-­‐to-­‐characterize	   intermediates,	   transition	   states,	   and	   products	   along	   their	  reaction	   path.23-­‐25	   The	   success	   of	   the	   computational	   enzymology	   approach	   was	  recognized	  in	  2013	  with	  a	  Nobel	  Prize.26	  The	  work	  in	  thesis	  explored	  the	  inhibition	  of	   CTX-­‐M	   β-­‐lactamase	   with	   tazobactam,	   with	   the	   objective	   of	   elucidating	   the	  mechanism	   of	   a	   bridged	   intermediate	   formation	   between	   Ser70	   and	   Ser130.	   The	  synthetic	   site	   of	   glucosamine-­‐6-­‐phosphate	  was	   also	   investigated	   to	   gain	   atomistic	  insight	  into	  the	  ring	  opening	  mechanism	  of	  fructose-­‐6-­‐phosphate.	  In	  the	  subsequent	  chapter,	   we	   will	   delve	   into	   how	   computational	   chemistry	   is	   applied	   to	   exploring	  enzymatic	  catalysis.	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2.1	  Introduction	  For	   centuries	   our	   species	   believed	   the	   world	   was	   governed	   by	   conventional	  physics,	   that	   is	  Newton’s	  Laws.	  As	  time	  progressed	  we	  discovered	  a	  world	  beyond	  what	  is	  visible	  to	  the	  naked	  eye,	  a	  quantum	  world	  of	  electrons,	  nuclei,	  protons,	  and	  various	  other	  quantum	  particles.	  We	  realized	  our	  previous	   laws	  of	  physics	  did	  not	  apply	   to	   this	  world	  and	   thus	  a	  new	  branch	  of	  physics	  was	  born;	  quantum	  physics.	  Computational	   chemists	  use	   this	  knowledge	  of	   the	  quantum	  world	  combined	  with	  the	   processing	   power	   of	   supercomputers	   to	   analyze	   chemical	   systems.1	   This	   has	  given	   an	   opportunity	   to	   provide	   significant	   insight	   into	   a	   variety	   of	   different	  chemical	  phenomena.	  	  Herein,	   this	   chapter	  details	  what	   led	   to	   the	  development	  of	   this	  powerful	   tool	  and	   the	   methodologies	   applied	   to	   the	   subsequent	   computational	   enzymology	  studies.	  The	  methodology	  of	  molecular	  mechanics	  and	  dynamics	  will	  be	  outlined.	  	  
2.2	  Quantum	  Mechanics	  	  The	   foundational	   equation	   of	   all	   methods	   used	   in	   this	   thesis	   is	   Schrodinger’s	  Equation.2	  In	  it	  is	  the	  wavefunction,	  which	  can	  provide	  all	  information	  of	  a	  chemical	  system.	  The	  time	  independent	  Schrodinger	  Equation	  is	  shown	  in	  Equation	  2.1:	  	   𝐻𝜓 = 𝐸𝜓	  	   	   	   	   	   Eq	  2.1	  	  It	   contains	   the	   term  𝐸,	   which	   is	   the	   energy	   of	   the	   system	   describe	   by	   the	  wavefunction,	  and	  the	  Hamiltonian	  (𝐻).	  The	  Hamiltonian	  can	  be	  expanded	  as	  a	  sum	  of	  its	  kinetic	  and	  potential	  energies	  as	  shown	  in	  Equation	  2.2:	  	  	   𝐻 = 𝑇 +   𝑉	  	   	   	   	   	   Eq	  2.2	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These	   terms	   can	   be	   expanded	   to	   various	   components	   based	   on	   the	   type	   of	  interactions	  as	  shown	  in	  Equation	  2.3:	  	   𝐻 = 𝑇! +   𝑇! + 𝑉!! +     𝑉!" +   𝑉!! 	  	   	   	   Eq	  2.3	  	  Here	  we	  have	  five	  terms,	  both	  𝑇!	  and	  𝑇! 	  are	  the	  kinetic	  energy	  operators	  of	  both	  nuclei	   and	   electrons,	   respectively.	   The	   potential	   terms	  𝑉!! ,	  𝑉!" ,	   and	  𝑉!! 	  are	   the	  interactions	   of	   nuclei-­‐nuclei,	   nuclei-­‐electron,	   and	   electron-­‐electron,	   respectively.2	  While	  in	  theory	  this	  equation	  could	  be	  used	  to	  solve	  all	  quantum	  chemical	  problems,	  it	   is	   unfortunately	   impossible	   to	   solve	   for	   all	   but	   the	   simplest	   of	   systems	   (e.g.,	  hydrogen	  atom).	  Fortunately,	  we	  can	  make	  several	  approximations	  to	  help	  simplify	  the	  complicated	  nature	  of	  this	  equation	  so	  as	  to	  enable	  at	  least	  accurate	  and	  reliable	  approximate	  solutions.	  There	   are	   two	   approximations	   made	   to	   simplify	   the	   Hamiltonian	   and/or	  wavefunction.	   The	   first	   is	   the	  Born	  Oppenheimer	   approximation	  which	   effectively	  states	  that	  due	  to	  the	  fact	  that	  the	  nuclei	  are	  significantly	  heavier	  and	  slower	  than	  the	  electrons,	  that	  from	  the	  perspective	  of	  the	  electrons	  the	  nuclei	  can	  be	  considered	  stationary.3	  Consequently,	  the	  kinetic	  energy	  of	  the	  nuclei	  is	  zero,	  and	  the	  potential	  energy	  of	  nuclei-­‐nuclei	   interactions	   is	   a	   constant	   and	   can	  be	   calculated	   separately	  and	  added	  back	  in	  when	  needed.	  The	   second	   approximation	   that	  we	   commonly	   invoke	   is	   the	  Molecular	  Orbital	  approximation	   in	   which	   the	   motions	   of	   the	   electrons	   can	   be	   assumed	   to	   be	  independent	   of	   each	   other.4	   As	   a	   result,	   the	   wavefunction	   can	   be	   written	   as	   a	  product	  of	  1-­‐electron	  functions.	  This	  creates	  1-­‐electron	  orbitals	  that	  are	  much	  easier	  to	  solve.	  Furthermore,	  it	  facilitates	  replacement	  of	  the	  two-­‐electron	  potential	  energy	  electron-­‐electron	   term,	  with	  what	   is	   effectively	   a	   one-­‐electron	   term.5	   Fortunately,	  there	  are	  methods	  that	  have	  been	  developed	  to	  incorporate	  electron	  correlation,	  but	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they	  come	  at	  significant	  computational	  costs.	  Thankfully,	  other	  methods	  have	  been	  developed	   that	   can	   accurately	   describe	   large	   chemical	   systems	   at	   a	   relatively	   low	  computational	  cost,	  that	  is	  density	  functional	  theory	  (DFT).	  	  Instead	  of	  gaining	  chemical	  insight	  through	  the	  wavefunction,	  density	  functional	  theory	  looks	  for	  a	  physically	  observable	  quality,	  the	  electron	  density.5	  Wavefunction	  methods	   are	   defined	   by	   four	   components;	   three	   spatial	   coordinates	   and	   one	   spin	  component.	   DFT	   removes	   the	   spin	   component	   and	   relies	   on	   the	   three	   spatial	  coordinates	  x,	  y,	  and	  z.	  It	  is	  for	  this	  reason	  DFT	  is	  less	  computationally	  taxing	  than	  wavefunction	  based	  methods.	  There	  are	  several	  different	  branches	  within	  DFT	  itself,	  however	   the	   common	   way	   to	   approach	   enzymatic	   systems	   has	   been	   through	  employing	  hybrid	  functionals.	  Hybrid	  functionals,	  like	  B3LYP,	  allows	  for	  a	  degree	  of	  electron	  exchange	  to	  be	  calculated.6-­‐8	  Other	  approaches,	  such	  as	  the	  M06	  suite,	  have	  been	   found	   to	   help	   describe	   non-­‐bonded	   and	   long	   range	   interactions.9,10	   Overall,	  DFT	   has	   been	   extremely	   successful	   in	   describing	   biochemical	   models	   and	   has	  become	   a	   standard	   approach	   for	   analyzing	   enzymatic	   systems	   at	   the	   atomic	  level.11,12	  	  	  
2.3	  Molecular	  Mechanics	  A	   common	   theme	   in	   computational	   chemistry	   is	   the	   balance	   of	   accurately	  describing	  a	  chemical	  system	  while	  maintaining	  reasonable	  costs.	  In	  a	  perfect	  world,	  every	   chemical	   system	   would	   be	   described	   with	   the	   highest	   accuracy	   possible,	  unfortunately	   our	   resources	   are	   limited.	   This	   is	   an	   especially	   important	  consideration	   when	   analyzing	   large	   systems	   such	   as	   proteins,	   which	   contain	  thousands	  of	  atoms.	  The	  exceedingly	  clever	  computational	  chemists	  of	  the	  past	  have	  created	   a	   compromise	   between	   cost	   and	   accuracy.	   To	   appreciate	   the	   particular	  approach	   of	   molecular	  mechanics	   (MM)	  we	  must	   return	   to	   our	   understanding	   of	  conventional	  physics.	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While	   our	  primary	   focus	   for	   quantum	  mechanic	   approaches	   are	   electrons,	  we	  ignore	  electrons	  in	  molecular	  mechanics	  and	  focus	  strictly	  on	  nuclei.1	  As	  one	  might	  expect,	  this	  eliminates	  the	  possibility	  of	  investigating	  any	  bond	  breaking/formation	  and	  therefore	  transition	  states.	  However,	  we	  now	  have	  a	  less	  computationally	  taxing	  way	   of	   representing	   bond	   distances,	   angles,	   dihedrals,	   van	   der	   Waals,	   and	  electrostatic	  interactions	  (Figure	  2.1).	  	  	  
	  
Figure	   2.1	   A	   ball	   and	   stick	   representation	   of	   the	   various	   forces	   calculated	   by	  molecular	  mechanics.	  	  	   Molecular	   mechanics	   allows	   for	   a	   description	   of	   the	   energy	   through	   a	  combination	  of	  these	  covalent	  and	  non-­‐covalent	  interactions	  (Equation	  2.4).	  	  	   𝐸!"!#$ = 𝐸!"#$ +   𝐸!!"#$ + 𝐸!"#$%"& +     𝐸!"!#$%&'$($)# +   𝐸!"#	  	   Eq	  2.4	  	  The	  𝐸!"#$ ,	  𝐸!"#$% ,	   and	  𝐸!"#$%"& terms	   represent	   the	   bond	   stretching,	   angle	  bending	  and	  angle	  torsion,	  respectively.	  While	  the	  𝐸!"!#$%&!"#"$% 	  and	  𝐸!"#	  term	  make	  up	  the	  non-­‐covalent	  electrostatics	  and	  van	  der	  Waal	  interactions,	  respectively.1	  It	  is	  important	  to	  note	  that	  molecular	  mechanics	  is	  an	  empirical	  approach	  and	  therefore	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relies	  upon	  parameters	   obtained	   from	  accurate	  high	   level	  ab	  initio	   calculations	  or	  from	  experiment.	  Fortunately,	   a	  variety	  of	  different	   force	   fields	  exist	   to	  accurately	  describe	   different	   systems.13-­‐15	   The	   force	   field	   used	   in	   this	   thesis	   is	   the	   Assisted	  Modeling	  Building	  with	  Energy	  Refinement	  (AMBER),	  an	  MM	  force	  field	  specifically	  designed	  for	  proteins	  and	  nucleic	  acids.15-­‐17	  	  
2.4	  Molecular	  Dynamic	  Simulations	  and	  Enzymes	  It	   is	   absolutely	   essential	   for	   a	   computational	   chemist	   to	   start	   with	   an	  appropriate	  starting	  structure	  when	  analyzing	  enzymatic	  systems.	  Proteins	  exist	  in	  a	   variety	   of	   conformations	   and	   assuming	   their	   structure	   is	   widely	   inaccurate.	  Determining	  a	  representative	  protein	  structure	  can	  be	  challenging,	  but	  fortunately,	  a	  plethora	  of	  structures	  have	  been	  elucidated	  through	  X-­‐ray	  and	  NMR	  data	  and	  are	  found	  on	  the	  Protein	  Data	  Bank	  website.18	  Even	  though	  x-­‐ray	  structures	  can	  provide	  an	   excellent	   starting	   point,	   we	   know	   that	   proteins	   are	   not	   static	   and	   are	   often	  described	   as	   fluid-­‐like.19	   We	   can	   overcome	   this	   limitation	   by	   using	   molecular	  dynamic	  simulations.	  Molecular	  dynamics	  provide	  us	   insights	  on	  how	  these	  atoms	  behave	  over	  time	  while	  maintaining	  a	  reasonable	  computational	  cost.20	  	  Before	  beginning	  our	  molecular	  dynamic	  simulations,	  there	  are	  several	  criteria	  we	   must	   consider	   to	   pick	   an	   appropriate	   starting	   structure	   from	   an	   X-­‐ray	  crystallographic	  image.	  This	  includes	  consideration	  of	  the	  resolution	  to	  be	  confident	  in	   the	  structural	  properties	  and	  the	   form	  of	   the	  enzyme,	   i.e.,	   is	   it	   in	  a	  non-­‐reactive	  form	  or	  reactive.	  Additionally,	  we	  must	  consider	  what	   types	  of	  modifications	  have	  been	   done	   to	   the	   protein	   to	   enable	   for	   crystallization.	   This	   includes	   residue	  mutations	  or	   the	  use	  of	   substrate	   analogs	  or	   inhibitors.	   Finally,	  we	  must	   consider	  the	  organism	  from	  which	  this	  structure	  was	  obtained.	  By	  considering	  these	  factors,	  we	  can	  make	  an	   informed	  decision	  on	  which	  structure	   is	   the	  most	  appropriate	   for	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the	   proposed	   study.	  Once	   an	   appropriate	   structure	   has	   been	   chosen,	  we	   can	   then	  begin	  setting	  up	  and	  running	  our	  molecular	  dynamic	  simulations.	  	  Molecular	   dynamic	   simulations	   follow	   a	   cyclic	   scheme	   for	   generating	   their	  trajectories.21	   Before	   the	   simulation	   can	   begin	   hydrogen	   atoms	   and	   protonation	  states	  are	  assigned	  and	  the	  system	  is	  parameterized	  based	  on	  the	  force	  field	  chosen.	  The	   system	   is	   then	   solvated	   and	   minimized.	   A	   brief	   equilibration	   period	   occurs	  allowing	  for	  annealing	  and	  finally	  the	  simulation	  begins.	  Trajectories	  are	  predicted	  based	  on	  Newtonian	  physics.	  The	  simulation	  continually	  predicts	   trajectories	  until	  the	  assigned	  time	  is	  reached.	  The	  length	  of	  the	  simulation	  is	  strictly	  dependent	  on	  the	  behaviour	  that	  is	  being	  investigated,	   that	   is	   to	   say,	   there	   is	   not	   a	   set	   time	   limit.19	   Once	   the	   simulation	   is	  complete,	   the	   trajectories	  are	   then	  analyzed	   through	  a	  variety	  of	   tools.	  Typically	  a	  cluster	   analysis	   is	   performed	   to	   pick	   a	   representative	   structure	   for	   subsequent	  calculations.	  We	   can	   also	   investigate	   the	   structural	   variation	   through	  a	   root-­‐mean	  squared	  deviation	  analysis	  by	  picking	  residues	  of	  interest,	  such	  as	  those	  nearby	  the	  active	  site,	  and	  substrates	  if	  necessary.22	  It	  is	  not	  surprising	  that	  much	  insight	  can	  be	  gained	  through	  molecular	  dynamic	  simulations	  alone,	  however	  in	  order	  to	  capture	  the	   reaction	   coordinates	   along	   a	   specific	   pathway	   we	   must	   employ	   quantum	  chemical	  methods.	  	  
2.5	  Quantum	  Mechanical	  Clusters	  and	  Proton	  Affinities	  While	  molecular	  mechanics	   and,	   by	   extension,	   molecular	   dynamics	   provide	   a	  reasonably	   accurate	  way	   to	   describe	   conformational	   dynamics,	   it	   fails	   to	   describe	  bond	  breakage	  or	  bond	  formation.	  One	  particular	  way	  to	  overcome	  this	  limitation	  is	  to	   use	   a	  methodology	   known	  as	   quantum	  mechanical	   clusters.23	   These	   are	   simple	  models	   that	   contain	   a	   small	   number	   of	   atoms,	   all	   of	   which	   are	   described	   using	   a	  quantum	   mechanics	   approach.	   In	   this	   thesis,	   the	   QM-­‐cluster	   models	   constructed	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were	  described	  using	  DFT,	  the	  specific	  methods	  used	  for	  each	  system	  are	  described	  in	   the	   upcoming	   chapters.	   They	   were	   used	   to	   calculate	   the	   proton	   affinities	   of	  several	   amino	   acid	   side	   chains	   particularly	   histidine’s	   imidazole	   and	   glutamate’s	  carboxyl	   group.	   This	   is	   calculated	   by	   finding	   the	   energy	   difference	   between	   the	  protonated	  form	  and	  its	  equivalent	  deprotonated	  form	  (Equation	  2.5).24	  	  
	   𝐸!"#$#%  !""#$#%& = 𝐸!"#$%&%'(&"! −   𝐸!"#$#%&$'( 	  	   	   Eq	  2.5	  	  
2.6	  Quantum	  Mechanic/Molecular	  Mechanic	  Models	  For	   a	   long	   time,	   QM-­‐clusters	   were	   the	   method	   of	   choice	   to	   study	   enzymatic	  systems	  and	  are	  still	  used	  today	  to	  give	  insights	  into	  possible	  transition	  structures.25	  They	  provide	  a	  means	  of	  including	  specific	  residues	  involved	  in	  catalysis,	  however,	  there	   are	   additional	   contributing	   factors	   that	   allow	   for	   a	   reaction	   to	   be	  enzymatically	   feasible.	   There	   is	   a	   different	   approach	   that	   can	   be	   taken	   and	   has	  gained	  much	  traction	  over	  the	  decades	  since	  DFTs	  development.	  It	  is	  known	  as	  the	  quantum	  mechanics/molecular	  mechanics	  method,	  or	  QM/MM	  for	  short	  and,	  as	  the	  name	   implies,	   provides	   a	   blend	   of	   quantum	  mechanics	   and	   molecular	   mechanics	  (Figure	   2.2)	   Its	   implementation	   has	   been	   successfully	   applied	   to	  many	   enzymatic	  systems	  and	  was	  recognized	  with	  the	  Nobel	  prize	  in	  2013.26	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Figure	   2.2	  An	  example	  of	   a	  QM/MM	  model,	   the	  MM	  region	   is	   represented	  by	   the	  wireframe	  structure,	  the	  QM	  region	  is	  represented	  as	  ball	  and	  sticks.	  	   A	  QM/MM	  model	  consists	  of	  two	  regions:	  a	  quantum	  mechanics	  region	  reserved	  for	   the	   significant	   residues,	   those	   involved	   in	   bond	   formation	   or	   breaking	   and/or	  stabilization	   of	   high	   energy	   transition	   states,	   and	   a	   molecular	   mechanics	   region	  which	  is	  made	  up	  of	  the	  remaining	  atoms.27	  It	  provides	  the	  higher	  accuracy	  afforded	  by	  QM	  calculations	  without	  having	  a	   large	   impact	  on	   the	   computational	   cost	   from	  the	  MM	  region.28	  This	  overcomes	  the	  limitation	  of	  QM-­‐clusters	  by	  providing	  a	  way	  to	  represent	  the	  protein’s	  environment	  rather	  than	  adding	  in	  corrections	  for	  it.	  Overall,	  there	  are	  two	  ways	  to	  represent	  a	  QM/MM	  model,	  subtractive	  and	  additive	  (Figure	  2.3).28,29	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Figure	   2.3	  A	   representative	   illustration	  of	   the	   two	   coupling	   schemes	   for	  QM/MM	  models,	  additive	  and	  subtractive.	  	  	  The	  additive	  method	  calculates	  the	  entirety	  of	  the	  MM	  region	  and	  QM	  region	  as	  follows	  in	  Equation	  2.6:	  	  	   𝐸!"/!! = 𝐸!" +   𝐸!! + 𝐸!"!!! 	  	   	   	   	   Eq	  2.6	  	  Where	  𝐸!"is	   the	  energy	  of	   the	  QM	  region,	  𝐸!!is	   the	  energy	  of	   the	  MM	  region	  and	  𝐸!"!!! 	  is	  the	  interaction	  energy	  between	  the	  two	  regions.	  	   Another	  approach,	  and	  the	  one	  specifically	  used	  in	  this	  thesis,	  is	  the	  subtractive	  method,	  also	  known	  as	  “Our	  own	  N-­‐layered	  Integrated	  molecular	  Orbital	  molecular	  Mechanics”	  (ONIOM).30	  The	  ONIOM	  approach	  is	  as	  follows	  in	  Equation	  2.7:	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𝐸!"#!$ = 𝐸!! +   𝐸!" − 𝐸!!  (!"  !"#$%&)	  	   	   	   Eq	  2.7	  	  Finally,	  it	  is	  important	  to	  consider	  how	  to	  appropriately	  set	  up	  a	  QM/MM	  model,	  specifically	   the	  boundary	  between	   the	  MM	  region	   and	   the	  QM	  region.31	  Generally,	  there	  are	  several	  guidelines	  to	  follow:	  	  	   1. The	   boundary	   must	   be	   set	   at	   least	   3	   bonds	   away	   from	   any	   bond	  breaking/forming	  2. The	  boundary	  must	  not	  be	  along	  a	  polar	  bond	  or	  cyclic	  structure.	  	  3. The	  boundary	  should	  ideally	  be	  set	  between	  a	  non-­‐polar	  C-­‐C	  bond.	  	  4. The	  boundary	  can	  only	  be	  represented	  by	  a	  single	  link	  atom.	  	   Ideally,	   most	   of	   these	   guidelines	   should	   be	   followed	   when	   constructing	   a	  QM/MM	  model	   to	   ensure	   correct	   charge	   distribution	   throughout	   the	   QM	   layer.	   A	  common	   theme	   has	   been	   set	   throughout	   this	   chapter	   and	   also	   arises	   in	   the	  discussion	  of	   these	  guidelines;	   there	   is	   a	  balance	  between	  computational	   cost	   and	  accuracy.	  Although	  including	  a	  functional	  group	  some	  distance	  away	  from	  the	  bond	  formation/breaking	   is	   ideal,	   one	  must	   strongly	   consider	   the	   effective	   cost	   of	   that	  addition.	   Therefore,	   chemical	   intuition	   and	   understanding	   the	   limitations	   of	   a	  particular	   method	   of	   choice	   is	   extremely	   vital	   in	   constructing	   suitable	  representative	  models	  of	  enzymatic	  systems.	  Despite	  this,	  the	  ONIOM	  approach	  has	  been	   proven	   to	   be	   successful	   in	   accurately	   describing	   enzyme	   reactions.32	   It	   can	  successfully	   identify	   reaction	   pathways	   and	   transition	   states	   for	   a	   variety	   of	  enzymatic	   systems.	   It	   is	   clear	   computational	   enzymology	   is	   a	   powerful	   and	  exceptional	  tool	  for	  understanding	  these	  diverse	  natural	  catalysts.	  	  	  
Chapter 2: Computational Approaches to Enzymology 
	   22	  
2.7	  Software	  	  Several	   types	   of	   software	   suites	   were	   utilized	   throughout	   this	   thesis.	   In	  particular,	  molecular	  dynamic	  simulations	  were	  prepared	  and	  visualized	  using	   the	  Molecular	   Operating	   Environment	   (MOE)33.	   MDs	   were	   run	   using	   NAMD34	   and	  AMBER1435.	  VMD36	  was	  utilized	  for	  molecular	  dynamic	  visualization.	  All	  QM-­‐cluster	  and	   QM/MM	   calculations	   were	   performed	   using	   the	   Gaussian	   09	   software	  package.37	   GaussView38	   was	   used	   to	   visualize	   all	   QM-­‐cluster	   and	   QM/MM	  calculations.	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3.1	  Introduction	  The	  rise	  of	  antibiotic-­‐resistant	  bacterial	   infections	   is	  a	  growing	  concern	   in	   the	  medical	   field	   and	   poses	   a	   serious	   threat	   to	   current	   treatments.1,2	   The	  widespread	  use	   of	   antibiotics	   has	   caused	   an	   emergence	   of	   bacterial	   populations	   capable	   of	  surviving	   the	   strongest	   antibiotics	   known	   to	   date.3,4	   One	   of	   the	   most	   common	  classes	   of	   antibiotics	   contain	   a	   β-­‐lactam	   ring	   system;	   resistance	   to	   this	   class	   is	  brought	  about	  by	  the	  action	  of	  β-­‐lactamase	  enzymes	  which	  hydrolytically	  cleave	  the	  β-­‐lactam	   ring,	   rendering	   them	   ineffective.5	   This	   has	   raised	   concerns	   of	   their	  continued	  use	  in	  fear	  that	  one	  day	  they	  will	  become	  obsolete.6	  	  β-­‐lactamases	   are	   divided	   into	   four	   classes	   depending	   on	   their	   structure	   and	  function.	  Class	  B	  are	  a	  metallo-­‐β-­‐lactamase	  containing	  a	  zinc	  (II)	  ion	  in	  their	  active	  site,	  where	  as	  class	  A,	  C,	  D	  employ	  a	  serinyl-­‐residue	  in	  their	  active	  site,	  believed	  to	  be	  responsible	  for	  hydrolyzing	  the	  lactam	  ring.7,8	  Overall	  their	  mechanism	  of	  action	  for	  the	  serinyl	  classes	  remains	  the	  same;	  hydrolysis	  of	  the	  lactam	  ring	  occurs	  in	  two	  steps	  (Scheme	  3.1).9-­‐13	  Once	  the	  substrate	  pencillin	  has	  bound	  to	  the	  active	  site	  (A),	  the	  serine	  nucleophilically	  attacks	  the	  carbonyl	  of	  the	  lactam	  in	  an	  acylation	  step	  to	  form	   an	   acyl-­‐enzyme	   intermediate	   (B).	   This	   is	   followed	   by	   a	   deacylation	   reaction	  which	   hydrolyzes	   the	   covalent	   bond,	   releasing	   the	   inactivated	   drug	   and	   restoring	  the	  free	  enzyme	  (C).	  	  
Scheme	  3.1.	  Reaction	  pathway	  of	  β-­‐lactam	  antibiotic	  hydrolysis.	  	  	  
	  
The	   CTX-­‐M	   β-­‐lactamase	   subclass	   is	   one	   of	   the	   most	   widespread	   extended-­‐spectrum	   β-­‐lactamases,	   named	   for	   their	   strong	   activity	   against	   cefotaxime	   (CTX)-­‐
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like	   antibiotics.14	   This	   subclass	   is	   commonly	   found	   in	   E.	   coli.	   Although	   they	   are	  considered	  a	  sub-­‐class	  of	  the	  Class	  A	  β-­‐lactamases,	  they	  have	  been	  shown	  to	  share	  less	   than	   40%	   homology	   with	   the	   TEM	   and	   SHV	   Class	   A	   β-­‐lactamases.14	   Their	  distinctive	   active	   site	   is	   smaller	   than	   their	   other	   Class	   A	   counterparts	   and	   it	   is	  believed	   the	   increased	   flexibility	   of	   their	   active	   site	   accounts	   for	   their	   increased	  activity	  against	  larger	  β-­‐lactam	  antibiotics.	  Unfortunately	  the	  nuances	  of	  their	  active	  sites	  are	  poorly	  understood.15	  To	   circumvent	   the	   action	   of	   β-­‐lactamases,	   β-­‐lactam	   antibiotics	   are	   often	   co-­‐administered	  with	  lactamase	  inhibitors	  to	  prevent	  deactivation	  of	  the	  antibiotic.16,17	  The	   most	   commonly	   used	   inhibitors	   approved	   by	   the	   FDA	   are	   sulbactam,	  tazobactam,	  and	  clavulanic	  acid	  (Figure	  3.1).18	  They	  employ	  a	  typical	  mechanism	  of	  inhibition,	  similar	  to	  the	  mechanism	  of	  antibiotic	  inactivation.9-­‐11	  Specifically,	  Ser70	  becomes	   deprotonated	   by	   Glu166	   or	   Lys73	   and	   then	   nucleophilically	   attacks	   the	  inhibitor’s	  lactam	  ring.19-­‐21	  Following	  the	  attack,	  an	  acylated	  intermediate	  is	  formed	  between	   the	   inhibitor	  and	   the	  Ser70	   residue.	  While	   the	   formation	  of	   this	   covalent	  bond	  is	  commonly	  known,	  it	  has	  been	  discovered	  that	  there	  are	  alternatives	  to	  this	  pathway.16	  	  
	  
Figure	  3.1.	  The	  chemical	  structure	  of	  the	  FDA	  approved	  β-­‐lactamases	  inhibitors.	  	   One	  strategy	  for	  developing	  inhibitors	  is	  to	  find	  a	  compound	  that	  has	  a	  greater	  affinity	  for	  the	  enzyme	  compared	  to	  antibiotics.	  Other	  factors	  are	  considered	  such	  as	  the	   rate	   of	   inhibition	   and	   IC50	   concentrations.22	   This	   raises	   the	   question	  why	   the	  FDA	  inhibitors	  remain	  effective	  against	  CTX-­‐M	  classes.	  The	  strategy	  for	  inhibition	  is	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to	   prolong	   the	   deacylation	   step	   of	   the	   mechanism.22	   Therefore,	   if	   the	   inhibitors	  follow	   a	   similar	   pathway	   to	   antibiotic	   inactivation	   the	   deacylation	   step	   should	   be	  similar,	  however	  this	   is	  not	  the	  case.	   It	  was	  postulated	  that	  these	   inhibitors	   follow	  many	  different	  alternative	  pathways	  thus	  prolonging	  the	  deacylation	  step.15	  	  A	   common	  mutation	   that	  occurs	   across	  Class	  A	  β-­‐lactamases	   is	   the	  Ser130Gly	  mutant.	  Previous	  studies	  have	  shown	  that	  Ser130	  appears	  to	  have	  two	  roles	  within	  the	   active	   site.23	   First,	   it	   participates	   in	   maintaining	   proper	   geometry	   for	  appropriate	  binding	  of	   inhibitors	  and	   lactam	  antibiotics.	  Secondly,	   the	  residue	  has	  been	  found	  to	  play	  a	  role	  in	  subsequent	  reactions	  that	  occur	  after	  Ser70’s	  attack.	  In	  the	   case	   of	   the	   CTX-­‐M	   Class	   A	   subclass,	   a	   recent	   study	   has	   identified	   a	   bridging	  intermediate	   formed	   in	   wild-­‐type	   CTX-­‐M	   β-­‐lactamases,	   however	   it	   cannot	   be	  identified	  in	  the	  S130G	  mutant.24	  While	   the	   covalent	   bond	   formation	   between	   Ser70	   and	   the	   lactam	   ring	   is	  commonly	   known,	   Ser130	   has	   been	   found	   to	   play	   a	   role	   during	   the	   pathway	   of	  inhibition.	   Following	   the	   formation	   of	   the	   covalent	   bond,	   Ser130	   is	   capable	   of	  performing	   its	   own	   nucleophilic	   attack	   on	   the	   inhibitors.	   This	   forms	   a	   strong	  covalent	  cross-­‐linked	  species	  between	  Ser70	  and	  Ser130,	   thus	  stabilizing	   the	  acyl-­‐enzyme	  intermediate	  and	  therefore	  providing	  a	  strong	  mode	  of	  inhibition	  (Scheme	  3.2).24	  Although	  this	  has	  been	  identified	  as	  a	  known	  intermediate,	  it	  is	  unclear	  how	  it	   is	   formed.	  The	  deprotonation	  of	   Ser130	  by	  a	  base	   can	  allow	   for	   its	  nucleophilic	  attack;	   however,	   the	   exact	   steps	   involved	   in	   the	   formation	   of	   the	   cross-­‐linked	  intermediate	  are	  unknown.	  It	   has	   been	   proposed	   that	   the	   formation	   of	   this	   cross-­‐linked	   species	   is	  dependent	  on	  the	  conformation	  of	  the	  enzyme’s	  active	  site.24	  The	  active	  site	  of	  CTX-­‐M	  9	  has	  been	  shown	  to	  exist	  in	  two	  conformations.	  In	  conformation	  one	  a	  hydrogen	  bond	   is	   formed	   between	   Lys73	   and	   Ser130,	   whereas	   in	   conformation	   two	   the	  hydrogen	  bond	  is	  not	  present.	   It	   is	  believed	  that	  the	  second	  conformation	   leads	  to	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the	   formation	   of	   the	   cross-­‐linked	   intermediate,	   allowing	   for	   the	   Ser130	   to	   readily	  attack	   the	   amine.	   A	   few	   concerns	   arise	   from	   this	   assumption.	   Given	   the	   flexible	  nature	  of	  CTX-­‐M’s	  active	  site,	  one	  would	  expect	  that	  the	  formation	  would	  not	  solely	  depend	  on	  one	  hydrogen	  bond.	  While	  the	  presence	  of	  the	  hydrogen	  bond	  may	  affect	  the	  nucleophilic	  capabilities	  of	  Ser130	  perhaps	  the	  flexible	  nature	  of	  the	  active	  site	  plays	  a	  more	  vital	  role.	  Investigating	  the	  nuances	  of	  this	  cross-­‐linking	  reaction	  could	  lead	  to	  the	  design	  of	  stronger	  inhibitors.	  	  
Scheme	  3.2.	  Reaction	  pathway	  of	  cross-­‐linked	  species	  formation	  with	  tazobactam.24	  	  
	  	  It	   is	   for	   this	   reason	   a	   variety	   of	   computational	   tools	   have	   been	   employed	   to	  investigate	   the	   complexity	   of	   this	   cross-­‐linked	   species	   formation.	   Docking	   was	  performed	   on	   the	   non-­‐active	   form	   of	   the	   enzyme	   to	   gain	   insight	   on	   the	  incorporation	  of	  the	  substrate.	  Molecular	  dynamics	  simulations	  were	  performed	  to	  provide	   insights	  on	  the	  specific	   inhibitor-­‐enzyme	  interactions	  and	  the	  dynamics	  of	  its	   active	   site.	   QM/MM	   methods	   were	   used	   to	   provide	   insights	   on	   the	   reaction	  pathway.	   In	   this	   study,	   we	   have	   attempted	   to	   deliver	   atomistic	   insight	   on	   what	  drives	   the	   formation	   of	   the	   cross-­‐linked	   species	   with	   the	   aim	   to	   provide	  opportunities	  for	  novel	  inhibitor	  design.	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3.2	  Computational	  Details	  
3.2.1	  Molecular	  Docking	  The	   X-­‐ray	   structure	   of	   CTX-­‐M-­‐9	   (PDB:	   2P74)	   was	   used	   as	   the	   model	   for	   all	  subsequent	  simulations.11	  All	  water	  molecules	  and	  counter	  ions	  were	  removed	  and	  any	  non-­‐native	  residues	  were	  reverted	  back	  to	   their	  native	   form.	  Tazobactam	  was	  manually	   docked	   into	   the	   active	   site	   using	   the	   X-­‐ray	   structure	   CTX-­‐M-­‐9	   linked	   to	  cefoxitin	  (PDB:	  1YMX)	  as	  a	  template.25	  	  	  
3.2.2	  Molecular	  Dynamics	  Preparation	   and	   analysis	   of	   the	   molecular	   dynamic	   (MD)	   simulations	   were	  carried	  out	  within	  the	  Molecular	  Operating	  Environment	  (MOE)	  program	  suite.26	  All	  MD	   simulations	  were	   run	  with	   the	  NAMD	  program.27	   Protonation	   states	   of	   active	  site	  residues	  were	  assigned	  using	  PROPKA	  within	  MOE	  followed	  by	  layer	  solvation	  around	   the	   boundaries	   of	   the	   protein	   to	   8	   Å.	   Protonation	   states	   of	   active	   site	  residues	  were	  assigned	  using	  PROPKA	  in	  MOE.28	  The	  solvated,	  docked	  structure	  was	  minimized	   using	   the	  AMBER12:EHT	  molecular	  mechanics	   forcefield	   until	   the	   root	  mean	  square	  gradient	  of	  the	  total	  energy	  was	  below	  0.21	  kJ	  mol−1	  Å-­‐1.29,30	  	  The	  MD	  simulation	  was	  subjected	  to	  annealing	  at	  constant	  volume	  and	  pressure	  as	  the	  temperature	  was	  raised	  from	  150	  to	  300	  K	  over	  150	  ps.	  This	  was	  followed	  by	  a	   20	   ns	   production	   run	   until	   an	   active	   conformation	  was	   formed.	   All	   subsequent	  simulations	   were	   run	   using	   the	   active	   form	   as	   a	   starting	   structure.	   The	   reactive	  complex	   MD	   was	   subjected	   to	   a	   production	   run	   of	   10ns	   while	   the	   intermediate	  complex	  of	  tazobactam	  covalently	  bound	  to	  Ser70	  ran	  for	  4	  ns.	  	  Cluster	   analysis	   was	   performed	   through	   root	   mean	   squared	   deviation	   of	   the	  active	   site	   residues	   and	   substrate.	  Through	   cluster	   analysis,	   the	   average	   structure	  with	   the	  most	   dominant	   conformation	  was	   obtained	   for	   each	  MD	   simulation	   and	  was	  used	  as	  a	  model	  for	  further	  QM/MM	  calculations.	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3.2.3	  QM/MM	  Calculations	  All	  QM/MM	  calculations	  were	  performed	  using	  the	  ONIOM	  method	  in	  Gaussian	  09	  program	  suite.31	  Optimized	  structures	  were	  obtained	  using	  the	  ONIOM	  method,	  specifically	   ONIOM(M062X/6-­‐31G(d):AMBER96)	   5D.32-­‐34	   Harmonic	   vibrational	  frequencies	  obtained	  at	  the	  optimization	  level	  of	  theory	  were	  conducted	  to	  identify	  the	  nature	  of	  the	  stationary	  points.	  Single	  point	  calculations	  were	  performed	  using	  ONIOM(M062X/6-­‐311+G(2df,p)	  5D:AMBER96)	  to	  obtain	  the	  relative	  energies.	  	  All	  QM/MM	  models	  were	   truncated	   from	   the	  previously	  mentioned	  molecular	  dynamic	   simulations.	   All	   residues	   and	   water	   molecules	   15	   Å	   away	   from	   the	  substrate,	   tazobactam,	   were	   included.	   The	   QM-­‐region	   contained	   the	   R-­‐groups	   of	  Ser70,	   Lys73,	   Ser130,	   Asn132,	   Glu166,	   Ser273,	   Arg276	   as	   well	   as	   the	   peptide	  backbone	  of	  Ser70	  and	  Ser130.	  The	  surrounding	  residues	  were	   treated	   in	   the	   low	  layer	   with	   AMBER96	   forcefield.	   All	   transition	   state	   structures	   were	   obtained	  through	   flexible	   scans	   with	   increments	   of	   0.1	   Å	   to	   0.05	   Å	   for	   refinement.	   	   This	  computational	   method	   of	   studying	   enzymes	   has	   been	   extensively	   used	   to	  characterize	   reactions,	   successfully	   identifying	   theoretical	   transition	   and	  intermediate	  structures	  and	  their	  relative	  energies.35-­‐37	  	  
3.3	  Results	  and	  Discussion	  
3.3.1	  The	  Reactive	  Complex	  	  The	  formation	  of	   the	  bridging	   intermediate	   is	   thought	  to	  be	   largely	  dependent	  on	  the	  conformation	  of	  Lys73	  relative	  to	  Ser130,	  that	  is,	  the	  presence	  or	  absence	  of	  a	  hydrogen	   bond	   will	   dictate	   Ser130’s	   involvement	   in	   the	   subsequent	   reaction.	  Herein,	   we	   explore	   various	   active	   site	   states	   through	   MD	   and	   QM/MM	   models.	  Specifically,	  we	  investigated	  the	  consequences	  of	  various	  protonation	  states:	  Lys73	  as	  protonated	  or	  neutral.	  We	  also	  gained	  insights	  on	  the	  consequences	  of	  the	  S130G	  variant.	  Each	  MD	  model	  generated	  a	  QM/MM	  model	  to	  investigate	  the	  mechanistic	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details.	   Figure	   3.2	   shows	   the	  MD	   results	   for	   the	   alternate	   protonation	   states.	   The	  RMSD	   produced	   by	   the	   MD	   simulation	   generated	   10	   clusters,	   each	   overlaid	   as	  shown	   in	   Figure	   3.2A.	   This	   overlay	   shows	   Lys73	   alternating	   a	   hydrogen	   bond	  between	   Ser130’s	   oxygen	   and	   its	   carbonyl	   backbone.	   A	   distance	   plot	   measured	  between	   the	   Lys73N…OSer130	   shows	   insignificant	   fluctuating	   between	   2.6	   to	   3.6	   Å	  (Figure	  3.3A).	  The	  MD	  suggests	  that	  Lys73	  may	  prefer	  to	  be	  in	  its	  protonated	  state.	  	  
	  
Figure	  3.2.	  Overlays	  of	  structures	  obtained	  from	  cluster	  analysis	  of	  RMSD	  produced	  from	  10ns	  production	  run	  of	  the	  reactive	  complex	  (A)	  Lys73	  in	  its	  protonated	  state	  and	  (B)	  Lys73	  in	  its	  neutral	  state.	  	   As	  previously	  mentioned,	  the	  exact	  protonation	  states	  of	  Lys73	  and	  Glu166	  is	  a	  matter	  of	  debate.	  Although	  the	  PROPKA	  analysis	  of	  our	  model	  showed	  Lys73	  in	  its	  protonated	   state,	   a	   separate	  MD	  was	  performed	  considering	  Lys73	  and	  Glu166	  as	  neutral.	  The	  RMSD	  of	  this	  particular	  run	  generated	  10	  clusters,	  an	  overlay	  is	  shown	  in	  Figure	  3.2B.	  The	  protonation	  state	  of	  Lys73	  seems	  to	  largely	  affect	  its	  interaction	  with	   Ser130’s	   hydroxyl.	   A	   distance	   plot	   shows	   a	   greater	   variance	   compared	   to	  Lys73’s	  protonated	  state,	  ranging	  from	  2.6	  to	  5.6	  Å	  (Figure	  3.3B).	  The	  Lys73	  residue	  maintains	  an	  interaction	  with	  Ser70’s	  hydroxyl	  and	  Ser130’s	  backbone	  carbonyl.	  	  
Chapter	  3:	  The	  Inhibition	  Mechanism	  of	  CTX-­‐M	  β-­‐Lactamases	  	  	  
36	  
	  
Figure	   3.3.	   A	   distance	   plot	   of	   Lys73N…OSer130	   over	   a	   10ns	   production	   run	   of	   the	  reactive	  complex	  with	  (A)	  Lys73’s	  protonated	  state	  and	  (B)	  Lys73’s	  neutral	  state.	  	   The	  impact	  of	  the	  S130G	  mutation	  was	  considered	  using	  an	  in	  silico	  mutagenesis	  MD	  run.	  The	  RMSD	  plot	  of	  this	  particular	  run	  shows	  high	  variance	  compared	  to	  the	  native	   active	   site,	   Figure	   3.4A	   shows	   a	   cluster	   overlay	   produced	   from	   the	   RMSD.	  Surprisingly,	   the	   mutation	   largely	   impacted	   Ser70	   causing	   it	   to	   exist	   in	   two	  conformations.	   Interestingly,	   Lys73	   maintains	   a	   consistent	   hydrogen	   bond	   with	  Gly130’s	  carbonyl	  backbone	  due	  to	  the	  lack	  of	  interaction	  with	  Ser130.	  The	  impact	  of	  this	  mutation	  could	  be	  from	  the	  large	  flexibility	  gained	  from	  the	  lack	  of	  Ser130’s	  hydroxyl,	  which	  is	  apparent	  from	  its	  RMSD	  plot	  (Figure	  3.4B).	  Specifically,	  the	  lack	  of	   interaction	  with	   Ser130’s	   hydroxyl	   appears	   to	   affect	   the	   overall	   stability	   of	   the	  three	  other	  residues;	  Lys73,	  Ser70,	  and	  Glu166.	  	  	  	  
	  
Figure	   3.4.	   Overlay	   structures	   (A)	   obtained	   from	   cluster	   analysis	   of	   RMSD	   (B)	  produced	  from	  10ns	  production	  run	  on	  the	  reactive	  complex	  of	  S130G	  variant.	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We	   wished	   to	   explore	   the	   effects	   of	   the	   protonation	   state	   of	   Lys73	   and	   the	  S130G	   variant	   on	   Ser70’s	  β-hydroxyl	   distance	   towards	   the	   substrate	   (Figure	   3.5).	  Although	   the	  protonation	   state	  appears	   to	  have	  an	  effect	  on	  Ser130’s	  geometry,	   it	  appears	   to	   have	   little	   effect	   on	   Ser70’s	   geometry.	   Interestingly,	   the	   S130G	  variant	  shows	  large	  variation	  in	  Ser70’s	  motion	  with	  its	  distance	  ranging	  from	  2.9	  to	  6.4	  Å.	  	  
	  
Figure	  3.5.	  A	  distance	  plot	  produced	  from	  a	  10ns	  production	  run	  on	  of	  the	  reaction	  complex	  of	  (A)	  Lys73	  in	  its	  protonated	  state,	  (B)	  Lys73	  in	  its	  neutral	  state,	  and	  (C)	  the	  S130G	  variant.	  	  
3.3.1.1	  The	  Reactive	  Complex	  with	  Protonated	  Lys73	  	  To	   gain	   further	   insight	   on	   the	   reactive	   complex,	   a	   QM/MM	   model	   was	  constructed	   from	   the	   highest	   average	   structure	   generated	   from	   the	   protonated	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Lys73	  MD	   run	   (Figure	   3.6).	  We	   explored	   the	   nucleophilic	   attack	   of	   Ser70	   on	   the	  substrate	   to	   determine	   the	   nature	   of	   Lys73	   and	   Glu166	   during	   the	   reaction.	   The	  optimized	  reactive	  complex	  (RC(Lys-­‐H+))	  showed	  a	  distance	  of	  2.83	  Å	  between	  Ser70’s	  
β-hydroxyl	  and	  the	  carbonyl	  of	  tazobactam.	  The	  RC(Lys-­‐H+)	  shows	  Ser70’s	  hydrogen	  of	  its	  β-hydroxyl	  pointing	  towards	  Glu166,	  suggesting	  it	  may	  act	  as	  a	  base	  during	  the	  reaction	   pathway.	   The	   transition	   state	   (TS(Lys-­‐H+))	   does	   confirm	   Glu166’s	  involvement	  as	  it	  abstracts	  Ser70’s	  proton	  initiating	  the	  nucleophilic	  attack	  with	  an	  energetically	  favourable	  barrier	  of	  66.0	  kJ	  mol-­‐1.	  	  	  
	  
Figure	  3.6.	  Relative	  energy	  surface	  obtained	  for	  the	  covalent	  formation	  of	  Ser70	  to	  tazobactam,	   with	   Lys73	   protonated	   and	   Glu166	   deprotonated	   in	   RC(Lys-­‐H+).	   See	  Computational	  Details.	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The	   lactam	   ring	   amide	   bond	   increases	   from	   1.40	   Å	   to	   1.50	   Å	   during	   Ser70’s	  approach.	  Moreover,	  TS(Lys-­‐H+)	  shows	  Lys73’s	  involvement	  as	  it	  moves	  closer	  to	  the	  amine	  of	  the	  lactam	  ring	  placing	  it	  at	  1.90	  Å.	  By	  comparison,	  in	  the	  reactive	  complex	  it	  is	  3.71	  Å	  away.	  Finally,	  once	  the	  ring	  is	  open	  at	  a	  distance	  of	  2.78	  Å	  in	  the	  IC(Lys-­‐H+),	  Lys73	  donates	  its	  proton	  to	  the	  amine	  giving	  an	  energy	  value	  of	  −165.6	  kJ	  mol-­‐1.	  
3.3.1.2	  The	  Reactive	  Complex	  with	  Neutral	  Lys73	  A	  model	   considering	  Lys73	  as	  neutral	  was	  constructed	   to	   investigate	  whether	  the	   neutral	   form	   provided	   a	   reasonable	   pathway	   of	   inhibition	   (Figure	   3.7).	   The	  
RC(Lys-­‐Neu)	  shows	  Ser70	  resting	  at	  distance	  of	  3.14	  Å	  away	  from	  the	  substrate,	  while	  a	  water	  molecule	  sits	  between	  Glu166	  and	  Lys73.	  The	  water	  molecule	  also	  shares	  a	  hydrogen	  bond	  with	  the	  substrate	  at	  a	  distance	  of	  1.95	  Å.	  	  	  
	  
Figure	  3.7.	  Relative	  energy	  surface	  obtained	  for	  the	  covalent	  formation	  of	  Ser70	  to	  tazobactam,	  with	  Lys73	  and	  Glu166	  both	  neutral	   in	  RC(Lys-­‐Neu).	   See	  Computational	  Details.	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As	   Ser70’s	   β-­‐hydroxyl	   approaches	   the	   substrate,	   a	   concerted	   reaction	   occurs	  with	   a	   proton	   shuttled	   to	   the	   nearby	   Lys73	   through	   the	   protonated	   Glu166	   via	   a	  bridging	   water	   molecule.	   This	   leads	   to	   deprotonation	   of	   Ser70	   from	   the	   newly	  deprotonated	  Glu166.	  This	  reaction	  proceeds	  through	  a	  late	  transition	  state,	  TS(Lys-­‐
Neu),	   which	   contains	   a	   protonated	   Lys73	   residue	   that	   forms	   a	   hydrogen	   bond	  network	   towards	   the	   nitrogen	   in	   the	   lactam	   ring.	   Concomitantly,	   the	   ring	   opens	  slightly	  at	  a	  distance	  of	  1.53	  Å	  compared	  to	  1.41	  Å	  in	  its	  RC(Lys-­‐Neu).	  Lys73	  shuttles	  a	  proton	  through	  the	  water	  molecule	  producing	  a	  barrier	  of	  182.5	  kJ	  mol-­‐1.	  Ultimately	  this	  leads	  to	  the	  intermediate	  IC(Lys-­‐Neu)	  with	  Ser70	  acylated	  at	  an	  energy	  of	  -­‐28.8	  kJ	  mol-­‐1.	  Interestingly,	  Lys73	  that	  started	  the	  reaction	  in	  its	  neutral	  form	  finishes	  in	  the	  same	  state.	  	  
3.3.2	  The	  Formation	  of	  the	  Bridging	  Intermediate	  In	   contrast	   to	   the	   experimental	   observation,	   both	   IC(Lys-­‐H+)	   and	   IC(Lys-­‐Neu)	   was	  found	  to	  produce	  an	  unfavourable	  geometry	  for	  the	  attack	  of	  Ser130	  on	  tazobactam.	  Thereby,	  we	  approached	  the	  model	  through	  another	  MD	  simulation.	  This	  simulation	  was	   performed	   on	   the	   intermediate	   complex	   of	   Ser70	   covalently	   attached	   to	  tazobactam.	   This	   produced	   an	   RMSD	   with	   9	   clusters	   (Figure	   3.8A).	   The	   MD	   run	  placed	   Ser130	   in	   a	   favourable	   orientation	   for	   nucleophilic	   attack	   as	   Lys73	   sits	  relatively	  close	  to	  act	  as	  a	  proton	  acceptor.	  This	  suggests	  Lys73	  plays	  a	  possible	  role	  in	   its	   deprotonation	   allowing	   for	   the	   attack	   on	   the	   tazobactam	   intermediate.	   A	  distance	  plot	  measured	  between	  Ser130’s	  oxygen	  and	  the	  expecting	  carbon	  that	   is	  supposed	  to	  attack	  shows	  a	  distance	  varying	  between	  3.2	  to	  6.0	  Å	  (Figure	  3.8B).	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Figure	   3.8.	   Overlay	   of	   structures	   (A)	   obtained	   from	   cluster	   analysis	   of	   RMSD	  produced	  from	  4ns	  production	  run	  of	  the	  intermediate	  complex	  with	  Lys73	  neutral.	  	  Distance	   plot	   (B)	   of	   Ser130’s	   oxygen	   to	   tazobactam’s	   carbon	   generated	   from	   4ns	  production	  run	  with	  Lys73	  neutral.	  	  A	  model	  with	   the	  Lys73	  protonated	  was	  considered,	  producing	  an	  RMSD	  with	  10	   clusters	   (Figure	   3.9).	   Interestingly,	   Ser130	   is	   placed	   in	   the	   proper	   orientation,	  however	   there	   is	  no	  base	  present	   to	  deprotonate	  Ser130.	   It	  would	  be	  unlikely	   for	  Ser130	  to	  attack	  tazobactam	  without	  a	  readily	  available	  proton	  acceptor	  nearby.	  	  	  
	  
Figure	  3.9.	  Overlay	  of	  structures	  obtained	  from	  cluster	  analysis	  of	  RMSD	  produced	  from	  4ns	  production	  run	  of	  the	  intermediate	  complex	  with	  Lys73	  protonated.	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This	   highlights	   the	   importance	   of	   Lys73	   acting	   as	   a	   proton	   donor	   during	   the	  formation	   of	   Ser70’s	   covalent	   bond.	   Its	   neutral	   state	   during	   the	   intermediate	  complex	   places	   it	   in	   optimal	   proximity	   to	   Ser130	   and	   leaves	   Ser130	   in	   good	  orientation	  relative	  to	  tazobactam.	  An	  MD	  run	  considering	  the	  mutant	  S130G	  was	  performed	  to	  explore	  the	  impact	  of	  this	  mutation	  on	  the	  intermediate	  complex.	  A	  RMSD	  analysis	  generated	  9	  clusters,	  overlaid	  in	  Figure	  3.10A.	  Interestingly,	  this	  showed	  little	  variation	  compared	  to	  the	  reactive	  complex	  MD	  simulation	   in	  Figure	  3.4.	  This	  may	  suggest	   that	   the	  mutation	  has	  a	  deeper	  impact	  on	  the	  initial	  reaction	  of	  Ser70’s	  attack	  on	  the	  lactam	  ring,	  while	  not	  having	  much	  of	  an	  effect	  once	  the	  covalent	  bond	  is	  formed.	  	  	  
	  
Figure	   3.10.	   Overlay	   structures	   (A)	   obtained	   from	   cluster	   analysis	   of	   RMSD	   (B)	  produced	  from	  4ns	  production	  run	  on	  the	  intermediate	  complex	  of	  S130G	  variant.	  	   A	   QM/MM	  model	   was	   constructed	   from	   the	   most	   frequent	   cluster	   generated	  from	  the	  Lys73	  neutral	  MD	  run.	  As	  stated	  previously,	  this	  model	  was	  considered	  for	  further	   insight	   as	   it	   provided	   Ser130	   with	   reasonable	   orientation	   and,	   more	  importantly,	  provided	  a	  base	  for	  its	  β-hydroxyl’s	  proton	  abstraction.	  The	  optimized	  
IC1	  places	  the	  attacking	  oxygen	  2.57	  Å	  away	  from	  the	  substrate	  while	  orientating	  its	  hydrogen	   1.83	   Å	   away	   from	   Lys73’s	   nitrogen	   (Figure	   3.11).	   Interestingly,	   the	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sulfone	   has	   dissociated	   from	   its	   ring	   configuration,	   showing	   a	   distance	   of	   3.14	   Å.	  This	  places	  the	  nitrogen-­‐carbon	  bond	  at	  1.28	  Å	  giving	  a	  double	  bond	  characteristic.	  	  	  
	  
Figure	  3.11.	  	  Relative	  energy	  surface	  obtained	  for	  the	  covalent	  formation	  of	  Ser130	  to	  tazobactam	  intermediate,	  see	  Computational	  Details.	  	   In	  TS,	   Ser130’s	  nucleophilic	   oxygen	   is	  placed	  at	   a	  distance	  of	  1.60	  Å	   from	   the	  substrate	  while	   its	   proton	   is	   directed	   towards	   Lys73	   at	   a	   distance	   of	   1.14	   Å.	   The	  nitrogen-­‐carbon	   bond	   has	   extended	   to	   1.39	   Å.	   Indeed,	   the	   attack	   of	   Ser130	   to	  tazobactam	  begins	  with	  its	  hydroxyl	  being	  deprotonated	  by	  Lys73	  (TS),	  producing	  an	  energy	  barrier	  of	  74.5	  kJ	  mol-­‐1,	  relative	  to	  IC1.	  Finally	  the	  bridging	  complex	  (IC2)	  is	  formed	  with	  a	  relative	  energy	  of	  64.7	  kJ	  mol-­‐1	  forming	  a	  bond	  length	  of	  1.48	  Å.	  The	  sulfinate	  remains	  dissociated	  at	  a	  distance	  of	  3.14	  Å	  while	  the	  nitrogen-­‐carbon	  bond	  retains	  a	  single	  bond	  at	  a	  distance	  of	  1.42	  Å.	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3.4	  Conclusion	  We	  have	  explored	   the	   inhibition	  mechanism	  of	  CTX-­‐M	  β-­‐lactamases	   through	  a	  molecular	  dynamic	  approach	  while	  considering	  various	  reaction	  pathways	  through	  QM/MM	  methodology.	  Specifically,	  we	  explored	  the	  impact	  of	  Ser130’s	  involvement	  during	   the	   reaction	   pathway.	  We’ve	   indicated	   Ser130’s	   involvement	   in	   two	   ways	  while	   highlighting	   the	   importance	   of	   the	   protonation	   states	   of	   both	   Glu166	   and	  Lys73.	  	  Ser130	   appears	   to	   have	   two	   roles	   in	   the	   active	   site	   of	   CTX-­‐M	  β-­‐lactamases.	   It	  provides	  stability	  to	  the	  reactive	  complex	  through	  a	  hydrogen	  bond	  interaction	  with	  Lys73	   and	   provides	   a	   separate	   nucleophilic	   attack	   on	   the	   covalently	   bonded	  substrate	   after	   Ser70’s	   attachment.	   While	   Lys73’s	   conformation	   does	   change	  slightly,	  its	  conformation	  has	  a	  less	  impact	  on	  the	  bridge	  formation	  than	  previously	  proposed.	   More	   importantly,	   the	   orientation	   of	   the	   intermediate	   complex	   once	  Ser70	  has	  covalently	  bonded	  to	  the	  substrate	  provides	  an	  opportunity	  for	  Lys73	  to	  deprotonate	  Ser130.	  	  Additionally,	   we’ve	   outlined	   the	   implications	   of	   Glu166	   and	   Lys73	   protonation	  states	  and	  perhaps	  further	  complicates	  the	  debate.	  Based	  on	  our	  models,	  Lys73	  can	  be	   in	   its	   protonated	   state	   or	   its	   neutral	   state	   during	   Ser70’s	   covalent	   bond	  formation.	  In	  the	  case	  of	  Lys73	  being	  protonated,	  Glu166	  acts	  as	  the	  base	  for	  Ser70	  while	   Lys73	   is	   able	   to	   readily	   donate	   its	   proton	   to	   the	   amine	   of	   the	   lactam	   ring.	  While	   in	   the	   alternative	   case,	   Lys73	   acting	   as	   the	   base,	   we’ve	   found	   that	   Lys73	  becomes	  protonated	  by	  Glu166	  through	  a	  mediating	  water	  molecule	  and	  then	  Ser70	  is	   deprotonated	   through	   Glu166’s	   carboxylate.	   Both	   scenarios	   provide	   a	   reaction	  pathway	   in	  which	   Lys73	   is	   later	   neutral,	   allowing	   for	   it	   to	   act	   as	   the	   base	   during	  Ser130’s	  nucleophilic	  attack.	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4.1	  Introduction	  Glucosamine-­‐6-­‐phosphate	   synthase	   (GlmS)	   is	   a	   critical	   enzyme	   in	   the	  biosynthesis	   of	   hexosamines.	   It	   catalyzes	   the	   rate-­‐limiting	   step	   of	   hexosamine	  formation	  via	  the	  conversion	  of	  fructose-­‐6-­‐phosphate	  to	  glucosamine-­‐6-­‐phosphate.1	  Ultimately,	   glucosamine-­‐6-­‐phosphate	   synthesis	   leads	   to	   the	   formation	   of	   UDP-­‐N-­‐acetylglucosamine.	   This	   product	   is	   a	   key	   molecule	   in	   the	   formation	   of	   bacteria’s	  peptidoglycan	   and	   fungi’s	   chitin.2,3	   This	  has	   led	   to	   the	   investigation	  of	  GlmS	  as	   an	  antimicrobial	   target.4,5	   Moreover,	   human	   GlmS	   has	   been	   found	   to	   have	   a	   role	   in	  glucose	  regulation	  and	  implications	  towards	  diabetes.6	  Intriguingly,	  overexpression	  of	  glutamine:fructose-­‐6-­‐phosphate	  amidotransferase	  (GFA)	  genes	  in	  pancreatic	  cells	  of	   transgenic	   mice	   has	   led	   to	   insulin	   resistance	   and	   mild	   type	   II	   diabetes.7	   In	  addition,	  increased	  activity	  of	  GlmS,	  due	  to	  high	  glucose	  or	  glutamine	  concentration,	  leads	   to	   vascular	   dysfunction.8	   It	   is	   clear	   this	   enzyme	   has	   many	   physiological	  implications	  thus	  understanding	  its	  precise	  catalytic	  nature	  could	  potentially	  lead	  to	  the	  design	  of	  inhibitors.	  	  GlmS	   belongs	   to	   a	   family	   of	   enzyme’s	   known	   as	   amidotransferases,	   a	   class	   of	  enzymes	   responsible	   for	   the	   catalytic	   activity	   of	   glutamine’s	   deamination	   to	   form	  glutamate	   and	   an	   aminated	   product.9	   Several	  members	   of	   this	   family	   are	   directly	  responsible	   for	   biosynthesis	   of	   purines	   and	   pyrimidines,	   amino	   acids,	   and	   other	  aminated	  products.9-­‐11	  While	  most	  amidotransferases	  can	  use	  exogenous	  ammonia	  as	   a	   source	   of	   nitrogen,	   GlmS	   remains	   unique	   in	   that	   it	   requires	   glutamine	   as	   its	  strict	  source.12	  GlmS,	  therefore,	  contains	  two	  catalytic	  sites,	  one	  for	  the	  deamination	  of	   glutamine,	   the	   other	   responsible	   for	   the	   synthesis	   of	   glucosamine-­‐6-­‐phosphate	  from	  fructose-­‐6-­‐phosphate	  (Fru-­‐6-­‐P).13	  	  GlmS	   is	   primarily	   responsible	   for	   the	   generation	   of	   glucosamine-­‐6-­‐phosphate,	  however	   each	   site	   can	   act	   individually.14,15	   Specifically,	   the	   enzyme	   catalyzes	   the	  hydrolysis	   of	   glutamine	   without	   the	   presence	   of	   Fru-­‐6-­‐P	   or,	   conversely,	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isomerization	   of	   Fru-­‐6-­‐P	   occurs	   in	   the	   absence	   of	   glutamine.	   This	   highlights	   the	  complexity	  of	  the	  overall	  synthesis	  of	  glucosamine-­‐6-­‐phosphate.	  The	  reaction	  occurs	  in	  three	  steps,	  the	  generation	  of	  ammonia	  from	  glutamine	  hydrolysis,	  the	  transfer	  of	  the	   ammonia	   to	  Fru-­‐6-­‐P,	   and	   finally	   the	   generation	  of	   glucosamine-­‐6-­‐phosphate.16	  GlmS	   achieves	   this	   remarkable	   cooperativity	   through	   an	   18	  Å	   channel	   connecting	  both	  the	  deamination	  site	  and	  the	  synthase	  site.17	  	  To	   prevent	   loss	   of	   ammonia	   to	   the	   outside	   environment,	   GlmS	   employs	   a	  protective	  mechanism	  via	  conformational	  changes.18	  Fru-­‐6-­‐P	  binds	  to	  the	  synthase	  site	  and	  undergoes	  ring	  opening,	  which	  begins	  to	  align	  the	  channel.	  Glutamine	  then	  binds	   to	   the	  glutaminase	  site	  and,	  prior	   to	   its	  hydrolysis,	   the	  channel	  opens	  and	  a	  protective	   Q-­‐loop	   closes	   over	   the	   site.18	   The	   reaction	   produces	   glutamic	   acid	   and	  glucosamine-­‐6-­‐phosphate	  all	  while	  insuring	  the	  ammonia	  produced	  is	  not	  lost	  to	  the	  surrounding	  environment.	  The	  sequential	  binding	  of	  the	  substrates	  tightly	  regulates	  this	  process,	  which	  is	  initiated	  by	  the	  binding	  and	  ring	  opening	  of	  Fru-­‐6-­‐P.	  	  Fru-­‐6-­‐P	  binds	  to	  the	  active	  site	  primarily	  through	  its	  phosphate	  group,	  forming	  a	  network	  of	  hydrogen	  bonds	  with	  Ser347,	  Gln348,	  Ser349,	  and	  Thr352.	  This	  places	  the	   substrate	   into	   the	   synthase	   site	  where	  Glu488,	  His504,	   and	  Lys603	  have	  been	  found	   to	   be	   involved	   in	   the	   ring	   opening	   of	   Fru-­‐6P	   and	   glucosamine-­‐6-­‐phosphate	  formation.17	   It	   has	   been	   proposed	   that	   the	   ring	   opening	   mechanism	   is	   strictly	   a	  result	  of	   the	  catalytic	  activity	  of	  His504.19,20	  Specifically,	  His504’s	   imidazole	  ring	   is	  expected	  to	  sit	   in	   its	  neutral	   form,	  and	  this	   initiates	  deprotonation	  of	  Fru-­‐6-­‐P’s	  O2	  hydroxyl	   (Scheme	   4.1).	   The	   ring	   begins	   to	   open	   and	   the	   newly	   formed	   oxyanion	  from	   the	   ether	   oxygen	   accepts	   a	   proton	   from	   H504.	   Indeed,	   kinetic	   analysis	   of	   a	  H504Q	   variant	   has	   shown	  decreased	   activity,	   suggesting	   its	   catalytic	   function.18	   A	  similar	  enzyme,	  glucosamine-­‐6-­‐phosphate	  deaminase,	  catalyzes	  the	  reverse	  reaction	  of	   glucosamine-­‐6-­‐phosphate	   to	   fructose-­‐6-­‐phoshate	   and	   ammonia.	   Interestingly,	  this	  enzyme	  has	  also	  been	  found	  to	  have	  a	  histidine	  involved	  its	  catalytic	  site	  acting	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as	   both	   a	   proton	   acceptor	   and	   donor.21,22	   Other	   ring	   opening	   enzymes	   such	   as	  phosphoglucose	   isomerase	   employ	   an	   acid-­‐base	   reaction	   with	   a	   catalytic	   triad	   of	  lysine,	  histidine	  and	  glutamic	  acid.23	  	  The	   precise	   details	   of	   how	   GlmS	   catalyzes	   the	   ring	   opening	   of	   Fru-­‐6-­‐P	   remains	  debated.	  While	  the	  presence	  of	  H504	  has	  been	  found	  to	  be	  catalytically	   important,	  other	  catalytic	  residues	  have	  been	  identified.	  Both	  Glu488	  and	  Lys485	  sit	  near	  the	  substrate,	  and	  are	  expected	  to	  act	  as	  proton	  acceptors	  in	  the	  subsequent	  reactions,	  suggesting	  they	  play	  a	  catalytic	  role	  in	  the	  active	  site.18	  	  	  
Scheme	  4.1.	  	  Proposed	  reaction	  for	  fructose-­‐6-­‐phosphate	  ring	  opening	  catalyzed	  by	  GlmS.18	  
	  	   We	   have	   employed	   a	   multiscale	   computational	   approach	   to	   obtain	   detailed	  information	  about	  catalytic	  nature	  of	  GlmS’s	   ring	  opening	  mechanism.	  Specifically,	  we	  used	  molecular	  dynamics	  and	  QM-­‐cluster	  approaches	  to	  appreciate	  the	  potential	  interactions	  and	  protonation	  states	  of	  key	  residues.	  We’ve	  gained	  further	  atomistic	  insight	   through	   an	   ONIOM	   QM/MM	   approach	   providing	   details	   on	   the	   reaction	  pathway	  of	  the	  ring	  opening	  mechanism.	  	  	  
4.2	  Computational	  Details	  
4.2.1	  Sample	  Preparation	  The	   X-­‐ray	   structure	   of	   glucosamine-­‐6-­‐phosphate	   synthase	   from	   Escherichia	   coli	  (PDB:	   2J6H)	   with	   glucose-­‐6-­‐phosphate	   and	   5-­‐oxo-­‐L-­‐norleucine	   was	   used	   as	   a	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starting	  structure	  for	  all	  subsequent	  simulations.13	  5-­‐oxo-­‐L-­‐norleucine	  and	  glucose-­‐6-­‐phoshate	  were	  converted	  to	  glutamine	  and	  fructose-­‐6-­‐phosphate,	  respectively.	  	  Protonation	   states	   were	   assigned	   with	   PROPKA24,25,	   histidyls	   were	   protonated	  based	   on	   their	   environment	   excluding	   the	   protonation	   state	   of	   H504	  where	   both	  states	  were	   considered.	   Topology	   and	   coordinate	   files	  were	   generated	  with	   tleap	  module	   of	   AMBER14.26	   Solvation	   was	   performed	   using	   87921	   TIP3P27	   water	  molecules	  in	  a	  cubic	  box	  with	  an	  edge	  length	  of	  ~141.1	  Å,	  this	  achieved	  a	  density	  of	  1.05g/cm	  after	  equilibration.	  	  	  
4.2.2	  Molecular	  Dynamics	  All	  MD	  simulations	  were	  performed	  using	  the	  AMBER1426	  program	  with	  graphics	  processing	  units	  version	  of	  pmemd.28,29	  The	   forcefields	   ff14SB30	  and	  TIP3P27	  were	  used	  to	  describe	  proteins	  and	  water	  molecules,	  respectively.	  Antechamber31,32	  was	  used	   to	   construct	   both	   glutamine	   and	   fructose-­‐6-­‐phosphate,	   using	   the	   ff14SB	  forcefield	   and	   RESP	   atomic	   charges.	   Gas	   phase	   optimizations	   at	   the	   HF/6-­‐31G(d)	  level	  of	  theory	  within	  the	  Gaussian0933	  program	  were	  used	  to	  calculate	  the	  charges	  of	  glutamine	  and	  fructose-­‐6-­‐phosphate,	  each	  capped	  methyl	  groups.	  A	  cut-­‐off	  of	  8	  Å	  was	   utilized	   in	   real	   space	   for	   long-­‐range	   electrostatics	   using	   the	   Particle-­‐Mesh	  Ewald	   (PME)	   procedure	   with	   periodic	   boundary	   conditions	   and	   NVT	   ensemble	  applied.34	  The	  SHAKE	  algorithm	  and	  a	  2	  fs	  timestep	  were	  used	  for	  equilibration	  and	  production	   by	   restricting	   the	   bond	   stretches	   from	   hydrogen	   atoms.	   Equilibration	  occurred	   in	   five	  stages	   following	  energy	  minimization;	   (1)	  a	  harmonic	  potential	  of	  50	   kcal	   mol-­‐1	   Å-­‐2	   for	   100	   ps	   at	   10	   K	   was	   used	   to	   restrain	   proper	   geometry	   of	  hydrogen	  atoms	  and	  all	  heavy	  atoms;	  (2)	  to	  optimize	  positions	  of	  water	  with	  respect	  to	  the	  protein,	  the	  same	  potential	  and	  conditions	  were	  used	  for	  100	  ps	  but	  without	  restraint	   applied	   to	   the	   oxygens	   of	   water;	   (3)	   the	   protein	   heavy	   atoms	   harmonic	  potential	  restraint	  was	  decreased	  to	  5	  kcal	  mol-­‐1	  Å-­‐2	  for	  100	  ps;	  (4)	  for	  100.0	  ps,	  the	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harmonic	  potential	  was	  removed;	  and	  (5)	  over	  a	  period	  of	  2000	  ps	  the	  system	  was	  incrementally	   heated	   to	   300	   K.	   In	   stage	   5	   the	   velocities	  were	   updated	   every	   100	  steps,	  and	  every	  10	  steps	  for	  equilibration	  stages	  1	  to	  4.	  Following	  equilibration,	  a	  production	  run	  of	  100	  ns	  was	  used.	  	  
4.2.3	  QM/MM	  Calculations	  The	   ONIOM	   method	   in	   Gaussian	   0933	   suite	   program	   was	   used	   for	   all	   QM/MM	  calculations.	   ONIOM(B3LYP/6-­‐31G(d):AMBER96)	   5D	   was	   used	   to	   optimize	   all	  subsequent	   structures.35-­‐37	   To	   access	   the	   nature	   of	   the	   stationary	   points,	   all	  optimized	  structures	  were	  analyzed	  through	  their	  harmonic	  vibrational	  frequencies	  obtained	   at	   the	   same	   level	   of	   theory	   as	   the	   optimized	   structures.	   Single	   point	  calculations	   were	   applied	   to	   the	   optimized	   structures	   using	   ONIOM(B3LYP/6-­‐311+G(2df,p):AMBER96).	  	  All	   QM/MM	   structures	   were	   obtained	   from	   the	   previously	   mentioned	   MD	  simulations.	   A	   representative	   structure	   was	   obtained	   through	   RMSD	   analysis	  choosing	  an	  appropriate	  structure	  once	  equilibration	  of	   the	  RMSD	  curve	  had	  been	  achieved.	  To	  represent	   the	  protein	  environment,	  all	  water	  molecules	  and	  residues	  15	   Å	   away	   from	   the	   substrate,	   Fru-­‐6-­‐P,	  were	   included.	   This	   produced	   a	  model	   of	  1912	   atoms.	   The	   substrate,	   Fru-­‐6-­‐P,	   and	   the	  R-­‐groups	   of	   Glu396,	   Glu481,	   Lys485,	  Glu488,	  His504,	  Lys603,	  as	  well	  as	  several	  nearby	  waters	  were	  included	  in	  the	  QM-­‐region,	  giving	  a	  total	  of	  105	  atoms.	  The	  AMBER96	  forcefield	  was	  used	  for	  all	  other	  residues	  and	  waters	  in	  the	  low	  layer.	  Flexible	  scans	  with	  increments	  of	  0.1	  Å	  to	  0.05	  Å	   were	   used	   to	   elucidate	   all	   transition	   state	   structures.	   This	   ONIOM	   method	  approach	  has	  been	  successfully	  used	  to	   identify	   the	  nature	  of	  enzymatic	  reactions,	  describing	   both	   transition	   and	   intermediate	   structures	   along	   the	   reaction	  pathways.38-­‐42	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4.3	  Results	  And	  Discussion	  
4.3.1	  The	  Protonation	  State	  of	  His504’s	  Imidazole	  The	  protonation	  state	  of	  His504	  will	  dictate	  the	  ring	  opening	  mechanism	  of	  GlmS	  with	   its	   imidazole	   potentially	   acting	   as	   a	   base	   or	   an	   acid	   to	   initiate	   the	   reaction.	  Previously	  it	  has	  been	  proposed	  that	  His504	  acts	  as	  a	  base.	  Its	  imidazole	  must	  sit	  in	  its	   neutral	   form	   to	   abstract	   the	   proton	   of	   the	  O2	   hydroxyl	   of	   Fru-­‐6-­‐P.	   In	   order	   to	  understand	  His504’s	  role	  in	  on	  the	  ring	  opening	  mechanism	  two	  protonation	  states	  of	  His504	  were	  assigned	  for	  molecular	  dynamics	  simulation.	  The	  root-­‐mean	  squared	  deviation	  (RMSD)	  of	  all	  atoms,	  relative	  to	  their	  initial	  crystal	  structure,	  within	  ~12	  Å	  of	  Fru-­‐6-­‐P	  were	  measured	  for	  each	  case	  (Figure	  4.1).	  	  	  
	  
Figure	  4.1.	  A	  RMSD	  plot	  of	  all	  atoms	  within	  ~12	  Å	  of	  Fru-­‐6-­‐P	  relative	  to	  their	  crystal	  structure	  over	  a	  100ns	  production	  run	  with	  His504	  protonated	  in	  blue	  and	  His504	  neutral	  in	  orange.	  	  	   Interestingly,	  the	  protonated	  His504	  model	  shows	  a	  narrow	  range	  of	  ~0.8	  to	  ~1.2	  Å	   over	   the	   100	   ns	   production	   run	   normalizing	   at	  ~1.0	   Å.	   This	   suggests	   that	  with	  His504	  in	  its	  protonated	  form,	  the	  active	  site	  of	  GlmS	  has	  similar	  positioning	  of	   its	  atoms	  relative	  to	  its	  crystal	  structure.	  Conversely,	  the	  neutral	  His504	  model	  shows	  a	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larger	   range	   from	   ~1.2	   to	   ~1.6	   Å,	   normalizing	   at	   ~1.4	   Å,	   suggesting	   a	   greater	  deviation	  from	  the	  reference	  crystal	  structure	  positions.	  	  A	   distance	   plot	   was	   constructed	   measuring	   the	   distance	   between	   His504’s	  nitrogen	   to	   Fru-­‐6-­‐P’s	   ether	   oxygen	   (Figure	   4.2).	   Over	   the	   course	   of	   the	   100ns	  production	   run,	   the	   neutral	   His504	   fluctuates	   widely	   from	   ~3.3	   Å	   to	   ~6.2	   Å,	  normalizing	   at	   an	   average	   distance	   of	   ~4.2	   Å.	   	   Conversely,	   the	   protonated	   form	  shows	  a	  much	  narrower	  range	  ~2.7	  Å	  to	  ~4.8	  Å	  normalizing	  at	  an	  average	  distance	  ~3.0	  Å.	  	  	  
	  
Figure	   4.2.	   A	   distance	   plot	   of	   His504N…OFru-­‐6-­‐P	   over	   a	   100ns	   production	   run	   with	  His504	   protonated	   in	   blue	   and	   His504	   neutral	   in	   orange.	   The	   chart	   on	   the	   right	  shows	  the	  occurrence	  of	  each	  distance	  as	  a	  percentage.	  	   Two	  representative	  structures	  were	  chosen	  from	  the	  MD	  simulations,	  showcasing	  the	  active	  site	  geometry	  for	  the	  protonated	  His504	  model	  as	  well	  as	  for	  the	  neutral	  model.	  The	  structures	  contain	  the	  substrate	  and	  His504’s	  interactions	  as	  well	  as	  the	  residues	   associated	   with	   phosphate	   binding.	   The	   representative	   structures	   are	  displayed	  in	  Figure	  4.3.	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Figure	  4.3.	   	  Representative	  structures	  selected	  from	  a	  100	  ns	  production	  run	  (see	  Computational	   Details)	   with	   His504	   (A)	   protonated	   and	   (B)	   neutral,	   distances	   in	  Ångstrom.	  Ligand	  interaction	  diagrams	  showcasing	  percentage	  of	  interactions	  over	  the	  simulation	  are	  also	  shown	  for	  the	  His504	  (C)	  protonated	  and	  (D)	  neutral.	  	  	   As	   shown,	   there	   are	   clear	   differences	   between	   the	   active	   sites,	   mainly	   in	   the	  positioning	   of	   His504.	   When	   His504	   sits	   in	   its	   neutral	   state	   it	   appears	   to	   have	  shifted	  away	   from	  Fru-­‐6-­‐P	  and,	   in	   fact,	   the	  hydroxyl’s	  proton	  that	   it	   is	  expected	  to	  abstract	  is	  6.82	  Å	  away.	  The	  hydroxyl	  itself	  has	  rotated	  away	  from	  the	  imidazole	  of	  His504	  and	  appears	  to	  share	  a	  hydrogen	  bond	  with	  a	  nearby	  peptide	  backbone	  (not	  shown).	   Over	   the	   course	   of	   the	   MD	   production	   run,	   the	   distance	   between	   the	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hydroxyl	  and	  the	   imidazole	  nitrogen	   fluctuated	  between	  ~4.9	  Å	   to	  ~8.5	  Å	  with	  an	  average	  distance	  of	  ~6.7	  Å	  (Figure	  4.4).	  	  Interestingly,	   the	  phosphate-­‐binding	   region	  was	   affected	   as	   shown	   in	   the	   ligand	  interaction	   diagrams	   (Figure	   4.3C	   &	   4.3D).	   Most	   of	   the	   hydrogen	   bond	   network	  remains	  consistent	  between	  the	  two	  models.	  Thr352,	  Ser347,	  and	  Ser349	  hydrogen	  bonds	  fluctuate	  slightly	  from	  each	  other,	  showing	  small	  variances	  of	  less	  than	  ~0.2	  to	  ~0.3	  Å.	  One	  large	  difference	  between	  the	  models	  arises	  from	  the	  hydrogen	  bond	  of	  Gln348’s	  amide	  peptide	  bond	  and	  Ser303’s	  hydroxyl.	  In	  the	  protonated	  model,	  the	  Gln348	  hydrogen	  bond	  shows	  a	  distance	  of	  ~1.9	  Å	  while	   in	   the	  neutral	  model	   the	  distance	   is	  ~3.0	  Å.	   In	   fact,	   in	   the	   neutral	  model,	   the	   percentage	   of	   interaction	   for	  Gln348	  dropped	  dramatically	  from	  83%	  to	  6%.	  Ser303’s	  interaction	  was	  also	  largely	  affected	  showing	  a	  drop	  from	  89%	  to	  17%.	  	  
	  
Figure	   4.4.	  A	  distance	  plot	  of	  His504N…HO-­‐Fru-­‐6-­‐P	  over	  a	  100ns	  production	  run	  with	  His504	  neutral.	  	  Most	   importantly,	   the	   two	   structures	  highlight	   an	   interesting	   role	   for	  His504	   in	  the	  ring	  opening	  mechanism.	  The	  protonated	  state	  forms	  a	  hydrogen	  bond	  with	  the	  ether	  oxygen	  of	  Fru-­‐6-­‐P	  at	  ~2.0	  Å.	  This	  distance	  remains	  fairly	  consistent	  during	  the	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course	   of	   the	   MD	   simulation	   showing	   a	   percentage	   of	   interaction	   of	   59%.	   This	  strongly	   suggests	   that	  His504	  may	   act	   as	   a	   proton	  donor	  during	   the	   ring	   opening	  mechanism,	   similar	   to	   glucosamine-­‐6-­‐phosphate	   deaminase.	   Furthermore,	   the	  neutral	  form	  sits	  at	  a	  relatively	  long	  distance,	  ~6.8	  Å,	  to	  act	  as	  a	  proton	  acceptor	  to	  Fru-­‐6-­‐P’s	   hydroxyl.	   It	  would	   be	   expected	   that	   this	   distance	  would	   be	   shorter	   and	  more	   consistent	   given	   that	   the	   proposed	  mechanism	   suggests	   His504’s	   imidazole	  acting	   as	   a	   base	   (Scheme	   4.1).	   In	   fact,	   the	   percentage	   of	   interaction	   shows	   the	  neutral	  His504	  residue	  having	  no	  interaction	  with	  the	  ligand	  over	  the	  course	  of	  the	  100ns	  run.	  	  	  
	  
Figure	  4.5.	  Calculated	  proton	  affinities	  of	  His504’s	  imidazole	  and	  Glu488’s	  carboxyl	  compared	  to	  their	  molecular	  equivalents.	  The	  calculated	  proton	  affinity	  of	  water	  is	  745.6	  kJ	  mol-­‐1.	  	  To	   gain	   further	   insights	   on	   the	   preferred	   protonation	   state	   of	   His504,	   we	  performed	   a	   proton	   affinity	   analysis	   on	   both	  His504	   and	  Glu488.	   PROPKA	   results	  suggested	  His504	  would	  be	   in	   its	  neutral	  state,	  however	   the	  MD	  results	  suggested	  otherwise.	  A	  protonated	  His504	  promotes	  the	  preferred	  geometry	  to	  act	  as	  a	  proton	  donor	  during	  the	  ring	  opening	  mechanism.	  The	  neutral	  form	  of	  His504	  did	  not	  show	  hydrogen	  bonding	  with	  the	  expected	  hydroxyl	  oxygen	  it	  is	  proposed	  to	  abstract.	  The	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proton	   affinities	   for	   both	   His504	   and	   Glu488	   in	   Figure	   4.5	   show	   that	   His504’s	  imidazole	  prefers	   to	  be	   in	   its	  protonated	   form	  while	  Glu488’s	   carboxyl	  prefers	   its	  neutral	  form.	  	  	  
4.3.2	  The	  Ring	  Opening	  Mechanism	  Initiated	  by	  His504	  Due	  to	  the	  structural	  similarities	  that	  GlmS	  shares	  with	  glucosamine	  6-­‐phosphate	  deaminase,	  we	   explored	   the	   effects	   of	   His504	   acting	   as	   the	   sole	   catalytic	   residue,	  that	   is,	   it	   acting	   initially	   as	   a	   proton	   donor	   and	   later	   as	   a	   proton	   acceptor.	   The	  optimized	  RC(His)	  placed	  His504’s	  hydrogen	  at	  a	  distance	  of	  1.77	  Å	   from	  Fru-­‐6-­‐P’s	  ether	  oxygen	  bond	  which	  shows	  a	  distance	  of	  1.45	  Å	  in	  Figure	  4.6.	  	  	  
	  
Figure	   4.6.	   Optimized	   structures	   of	   the	   reactant	   complex	   (RC(His)),	   intermediates	  (IM(His)),	  and	  transition	  structures	  (TS(His))	  of	  the	  ring	  opening	  mechanism	  catalyzed	  by	  His504,	  highlighting	  key	  residues	  and	  relevant	  distances	  in	  Ångstrom.	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The	   reaction	   begins	   with	   His504	   donating	   its	   proton	   to	   the	   ether	   oxygen,	  proceeding	  through	  TS1(His)	  with	  a	  potential	  energy	  barrier	  of	  72.7	  kJ	  mol-­‐1	  relative	  to	  RC(His)	  (Figure	  4.7).	  The	  C2-­‐O	  ether	  bond	  lengthens	  to	  a	  distance	  of	  1.52	  Å	  while	  a	  nearby	  water	  molecule	  (W1)	  rotates	  to	  hydrogen	  bond	  with	  His504	  at	  a	  distance	  of	  2.46	  Å.	  Interestingly,	  the	  C2	  hydroxyl,	  that	  is	  expected	  to	  form	  the	  carbonyl	  once	  the	  ring	   has	   opened,	   has	   rotated	   to	   form	   a	   hydrogen	   bond	   with	   W1’s	   oxygen	   at	   a	  distance	  of	  1.90	  Å.	  	  
IM1(His)	   forms	  with	   a	   relative	   energy	   of	   69.9	   kJ	  mol-­‐1	  where	   the	   ether	   bond	  has	  lengthened	   to	   1.56	   Å.	   The	   newly	   formed	   oxonium	   ion	   is	   hydrogen	   bonded	   to	  His504’s	  nitrogen,	  while	  W1	  and	  the	  C2	  hydroxyl	  forms	  a	  hydrogen	  bond	  network	  in	  a	   geometry	   capable	   of	   proton	   shuttling.	   Indeed,	   the	   proton	   shuttle	   occurs	   along	  
TS2(His)	  with	  a	  relative	  energy	  of	  107.2	  kJ	  mol-­‐1.	  	  
	  
Figure	   4.7.	   Potential	   energy	   surface	   obtained	   for	   the	   ring	   opening	   mechanism	  catalyzed	  by	  His504,	  see	  Computational	  Details.	  	  Finally,	  the	  ring	  is	  opened	  in	  IM2(His)	  which	  has	  a	  potential	  energy	  of	  54.7	  kJ	  mol-­‐1	  relative	  to	  RC(His).	  The	  ether	  bond	  has	  broken,	  with	  the	  atoms	  2.84	  Å	  away	  from	  each	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other.	  The	  protonated	  N3	  of	  His504	  shows	  a	  distance	  of	  2.03	  Å	  to	  W1	  and	  2.05	  Å	  to	  the	  newly	  protonated	  oxygen	  of	  Fru-­‐6-­‐P.	  W1	  also	  maintains	  its	  hydrogen	  bond	  with	  the	  carbonyl	  oxygen	  at	  a	  distance	  of	  1.92	  Å.	  	  
4.3.3	  The	  Ring	  Opening	  Mechanism	  Initiated	  by	  Glu488	  The	  initial	  RC(His/Glu)	  optimized	  from	  the	  MD	  production	  run	  showed	  Glu488	  in	  its	  deprotonated	   state	   as	   calculated	   by	   the	   proton	   affinities,	   but	   also	   showed	   its	  geometry	  in	  agreement	  to	  act	  as	  a	  base	  during	  the	  ring	  opening	  mechanism	  (Figure	  4.8).	  The	  RC(His/Glu)	  places	  one	  of	  the	  carboxyl	  oxygen	  atoms	  of	  Glu488	  at	  a	  distance	  of	   1.70	   Å	   from	   the	   C3	   hydroxyl	   of	   Fru-­‐6-­‐P.	   Moreover,	   this	   promoted	   the	   C2	  hydroxyl’s	  proton,	  the	  one	  expected	  to	  form	  the	  carbonyl,	  to	  share	  a	  hydrogen	  bond	  with	  the	  C3	  hydroxyl	  at	  a	  distance	  of	  2.27	  Å.	  This	  provided	  an	  environment	  where	  a	  proton	  shuttle	  could	  occur	  across	  the	  substituent	  hydroxyls	  to	  the	  carboxyl	  oxygen	  of	   Glu488.	   The	   interaction	   diagram	   of	   Glu488	   shows	   a	   relatively	   consistent	  interaction	   with	   the	   C3	   hydroxyl	   of	   Fru-­‐6-­‐P	   at	   46%	   occurrence,	   Figure	   4.3C.	  Therefore	  the	  ring	  opening	  mechanism	  catalyzed	  by	  Glu488	  was	  considered.	  Glu488	   abstracts	   the	   proton	   from	   the	   C3	   hydroxyl	   to	   form	   TS1(His/Glu)	   with	   a	  potential	   energy	   barrier	   of	   70.0	   kJ	  mol-­‐1	   relative	   to	   the	  RC(His/Glu)	   (Figure	   4.9).	   As	  shown	  in	  Figure	  4.8,	  TS1(His/Glu)	  begins	  to	  form	  an	  oxyanion.	  Two	  water	  molecules	  (W1	  and	  W2	   in	  Figure	  4.8)	   form	  hydrogen	  bonds	  with	   the	   incipient	  oxyanion	  at	  a	  distance	  of	  1.97	  Å	  and	  2.12	  Å,	  respectively.	  Interestingly,	  the	  hydrogen	  bond	  shared	  between	  the	  C3	  hydroxyl	  has	  increased	  in	  distance	  from	  2.27	  Å	  in	  the	  RC(His/Glu)	  to	  2.36	  Å	  in	  TS1(His/Glu);	  however	  in	  IM1(His/Glu)	  this	  bond	  returns	  to	  relatively	  the	  same	  distance	  at	  2.26	  Å.	  IM1(His/Glu)	  has	  	  a	  relative	  energy	  of	  59.6	  kJ	  mol-­‐1,	  forming	  a	  stable	  oxyanion	  intermediate	  that	  is	  stabilized	  through	  W1,	  W2	  and	  the	  C3	  hydroxyl.	  The	  hydrogen	  bonds	  shared	  with	  W1	  and	  W2	  during	  the	  TS1(His/Glu)	   formation	  shorten	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at	   a	   distance	   of	   1.95	   Å	   and	   1.88	   Å,	   respectively.	   A	   hydrogen	   bond	  with	   Glu488’s	  newly	  formed	  carboxylic	  acid	  further	  stabilizes	  the	  oxyanion	  at	  a	  distance	  of	  1.81	  Å.	  	  
	  
Figure	  4.8.	  Optimized	  structures	  of	  the	  reactant	  complex	  (RC(His/Glu)),	  intermediates	  (IM(His/Glu)),	   and	   transition	   structures	   (TS(His/Glu))	   of	   the	   ring	   opening	  mechanism	  catalyzed	  by	  Glu488	  and	  His504,	  highlighting	  key	  residues	  and	  relevant	  distances	  in	  Ångstrom.	  	  The	   reaction	  proceeds	   through	  TS2(His/Glu)	  where	   the	  C2	  hydroxyl’s	   hydrogen	   is	  deprotonated	  by	  the	  newly	  formed	  C3	  oxyanion	  in	  IM1(His/Glu)	  with	  a	  relative	  energy	  barrier	  of	  91.5	  kJ	  mol-­‐1.	  In	  TS2(His/Glu)	  the	  proton	  is	  1.25	  Å	  away	  from	  the	  oxyanion.	  A	  newly	  formed	  oxyanion	  appears	  in	  IM2(His/Glu)	  stabilized	  by	  hydrogen	  bonding	  to	  the	   C1	   and	   C3’s	   hydroxyl’s	   hydrogens	   at	   a	   distance	   of	   2.02	   Å	   and	   1.93	   Å,	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respectively,	  as	  well	  as	  a	  water	  molecule	  (W3	  in	  Figure	  4.8)	  at	  a	  distance	  of	  1.67	  Å.	  His504	   has	   moved	   closer	   to	   the	   ether	   oxygen	   of	   Fru-­‐6-­‐P	   when	   compared	   to	   the	  
RC(His/Glu),	  moving	  from	  1.75	  Å	  to	  1.64	  Å.	  This	  produced	  a	  potential	  energy	  of	  39.3	  kJ	  mol-­‐1	  relative	  to	  the	  RC(His/Glu).	  	  	  
	  
Figure	   4.9.	   Potential	   energy	   surface	   obtained	   for	   the	   ring	   opening	   mechanism	  catalyzed	  by	  Glu488	  and	  His504,	  see	  Computational	  Details.	  	   Finally,	  the	  ring	  begins	  to	  open	  as	  His504	  begins	  to	  donate	  its	  proton	  to	  the	  ether	  oxygen	   of	   Fru-­‐6-­‐P	   in	  TS3(His/Glu)	   producing	   a	   relative	   energy	   difference	   of	   47.6	   kJ	  mol-­‐1	  with	   respect	   to	  RC(His/Glu).	   The	   proton	   is	   distanced	   at	   1.19	   Å	   from	   the	   ether	  oxygen	  as	   it	  moves	   away	   from	   the	   incipient	   carbonyl	   at	   a	  distance	  of	   1.74	  Å	  with	  respect	  to	  the	  carbon.	  The	  C2	  oxygen	  remains	  stabilized	  by	  the	  C1	  and	  C3	  hydroxyl’s	  at	  a	  distance	  of	  2.11	  and	  2.08	  Å,	  respectively,	  while	  W3’s	  hydrogen	  bond	  is	  distanced	  at	  1.79	  Å.	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The	  Fru-­‐6-­‐P	  open	  structure,	  IM3(His/Glu),	  has	  a	  relative	  energy	  of	  -­‐89.0	  kJ	  mol-­‐1	  with	  respect	  to	  RC(His/Glu).	  The	  newly	  formed	  C5	  hydroxyl,	  previously	  the	  ether	  oxygen,	  is	  2.74	   Å	   from	   the	   carbonyl’s	   carbon	   atom,	   while	   it	   shares	   a	   hydrogen	   bond	   with	  His504	   at	   a	   distance	   of	   1.70	   Å.	   Glu488	   further	   stabilizes	   the	   newly	   formed	  intermediate	   sharing	   a	   hydrogen	   bond	  with	   the	   carbonyl	   oxygen	   at	   a	   distance	   of	  2.15	  Å.	  	  	  
4.4	  Conclusion	  In	   the	   present	   study,	   we	   have	   taken	   a	   complimentary	   approach	   to	   outlining	  glucosamine-­‐6-­‐phosphate	   synthase	   catalytic	   ring	   opening	  mechanism	   through	   the	  use	   of	   molecular	   dynamics	   and	   QM/MM	   models.	   Previously,	   the	   mechanism	  proposed	   His504	   acting	   as	   the	   sole	   residue	   responsible	   for	   the	   ring	   opening	  mechanism	   acting	   as	   both	   the	   proton	   acceptor	   and	   donator,	   however	   our	   results	  suggest	  an	  alternative	  pathway	  may	  occur.	  The	  molecular	   dynamic	   simulations	   performed	   show	   that	  when	  His504	   is	   in	   its	  neutral	   state	   the	   geometry	   and	   distance	   relative	   to	   the	   substrate	   is	   affected.	   The	  hydroxyl	   it	   is	   expected	   to	  deprotonate	   sits	   at	   an	   average	  distance	  of	  ~6.7	  Å	   away	  throughout	  the	  100	  ns	  run.	  Alternatively,	  the	  molecular	  dynamic	  simulations	  show	  that	  when	  His504	  is	  protonated	  it	  sits	  at	  a	  distance	  of	  ~3.0	  Å	  from	  the	  ether	  oxygen	  of	   Fru-­‐6-­‐P,	   maintaining	   a	   consistent	   hydrogen	   bond.	   Interestingly,	   our	   proton	  affinity	   calculations	   show	   that	   His504	   prefers	   to	   be	   in	   its	   protonated	   state	   in	   the	  reactive	  complex.	  	  The	   catalytic	   ring	   opening	   mechanism	   was	   further	   explored	   with	   a	   QM/MM	  approach.	  The	  ring	  opens	  with	  a	  cooperative	  effort	  between	  His504	  and	  Glu488.	  A	  stepwise	   proton	   shuttle	   occurs	   across	   the	   substituent’s	   hydroxyls	   as	   Glu488	  initiates	  the	  reaction	  through	  proton	  abstraction	  from	  the	  C3	  O-­‐H	  group.	  This	  led	  to	  a	  potential	  energy	  barrier	  of	  91.5	  kJ	  mol-­‐1	  along	  the	  reaction	  pathway.	  Conversely,	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we	   investigated	   His504	   acting	   as	   the	   sole	   catalytic	   residue,	   initiating	   the	   ring	  opening	   by	   donating	   its	   proton	   to	   the	   ether	   oxygen.	   This	   reaction	   followed	   a	  stepwise	  mechanism	  giving	  a	  potential	  energy	  barrier	  of	  107.2	  kJ	  mol-­‐1.	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5.1	  Conclusions	  	  In	  this	  thesis,	  a	  multifaceted	  computational	  approach	  was	  taken	  to	  explore	  two	  enzymatic	   systems	   involved	   in	   ring	   opening	   mechanisms.	   The	   mechanism	   of	  inhibition	  of	  a	  β-­‐lactamase	  inhibitor	  was	  explored	  and	  the	  ring	  opening	  mechanism	  of	  glucosamine	  6-­‐P	  synthase’s	  substrate	  fructose-­‐6-­‐phosphate	  was	  also	  identified.	  	  In	   chapter	   3,	   the	   inhibition	   of	   CTX-­‐M	   β-­‐lactamase	   was	   explored	   with	   the	  inhibitor	  tazobactam.	  Several	  approaches	  were	  taken	  to	  explore	  the	  nuances	  of	  the	  enzyme’s	  hydrolytic	  activity	  including	  molecular	  dynamic	  simulations	  and	  quantum	  mechanics/molecular	  mechanics	   (QM/MM)	  models.	   In	  particular,	   the	   formation	  of	  the	   bridging	   intermediate	   between	   Ser70	   and	   Ser130	  was	   elucidated.	   Previously,	  the	   proposed	   mechanism	   stated	   that	   Ser130’s	   involvement	   in	   the	   reaction	   was	  primarily	   a	   result	   of	   Lys73’s	   hydrogen	   bonding.1	   Specifically,	   if	   Lys73	   shared	   a	  hydrogen	  bond	  with	  Ser130,	  the	  bridging	  intermediate	  would	  not	  form.	  Our	  results	  show	   that	  Ser130’s	   involvement	   is	   independent	  of	  Lys73’s	   interactions	  during	   the	  reaction	   complex.	   Moreover,	   once	   Ser70’s	   covalent	   attachment	   has	   occurred,	   and	  the	  intermediate	  complex	  is	  formed,	  the	  dynamics	  of	  the	  enzyme	  play	  an	  important	  role.	   The	   dynamics	   of	   the	   intermediate	   complex	   allows	   for	   Ser130’s	   proper	  orientation	  where	   it	   is	   deprotonated	  by	   Lys73	   allowing	   for	   its	   nucleophilic	   attack	  ultimately	   forming	   the	   bridge	   intermediate.	   The	   structure	   and	   positioning	   of	  acylated	  intermediate	  should	  be	  taken	  into	  consideration	  for	  future	  inhibitor	  design	  with	   the	   potential	   of	   designing	   one	   that	   promotes	   the	   bridging	   intermediate	  formation.	  We	  also	  explored	  the	  consequences	  of	  the	  various	  protonation	  states	  of	  the	  catalytic	  residues	  and	  have	  identified	  that	  each	  scenario	  leads	  to	  a	  neutral	  Lys73,	  allowing	  it	  to	  be	  readily	  available	  for	  Ser130’s	  deprotonation.	  	  In	   chapter	   4,	   the	   synthase	   site	   of	   glucosamine-­‐6-­‐phosphate	   synthase	   was	  explored	   through	   long	   time	   scale	   molecular	   dynamics	   simulations,	   quantum	  mechanical	  clusters,	  and	  quantum	  mechanics/molecular	  mechanics	  models.	  Current	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literature	   has	   suggested	   the	   catalytic	   ring	   opening	   mechanism	   of	   fructose-­‐6-­‐phosphate	   occurred	   through	   a	   neutral	   His504	   residue.2	   Specifically,	   His504	   is	  proposed	   to	   act	   initially	   as	   the	   base	   for	   deprotonation	   of	   the	   C2-­‐OH.	   Our	   results	  indicate	   that	   the	  neutral	  His504	   shows	  no	   interaction	  with	   the	   substrate	  during	  a	  100ns	   molecular	   dynamic	   simulation.	   We	   have	   also	   shown	   that	   this	   residue	   in	  particular	  prefers	   to	  be	   in	   its	  protonated	  state	  as	   indicated	  by	  both	   the	  calculated	  proton	  affinities	  and	  its	  overall	  of	  interaction	  with	  the	  substrate	  during	  simulations.	  The	  role	  of	  His504	  was	  further	  highlighted	  as	  we	  explored	  the	  reaction	  coordinate	  of	   the	   ring	   opening	   mechanism.	   While	   the	   protonated	   His504	   shows	   a	   feasible	  energy	  barrier,	  an	  alternative	  mechanism	  was	  explored	  involving	  a	  concerted	  effort	  between	  Glu488	  and	  His504.	  Our	  results	  indicate	  that	  the	  reaction	  proceeds	  through	  a	   stepwise	   fashion	   with	   the	   reaction	   being	   initiated	   by	   Glu488	   through	   proton	  abstraction	  of	  fructose-­‐6-­‐	  phosphate’s	  C3	  hydroxyl.	  This	  ultimately	  leads	  to	  His504’s	  involvement	  by	  protonation	  to	  the	  ether	  oxygen	  of	  fructose-­‐6-­‐phosphate.	  	  The	   work	   in	   this	   thesis	   highlights	   the	   significance	   of	   taking	   a	   multi-­‐faceted	  computational	   approach.	   Severe	   limitations	   would	   arise	   if	   restricted	   to	   a	   specific	  technique.	   By	   approaching	   enzymatic	   systems	   through	   molecular	   dynamics	   and	  quantum	   mechanics/molecular	   mechanics,	   the	   pitfalls	   of	   one	   method	   can	   be	  compensated	   by	   the	   other.	   The	   combination	   allows	   for	   deeper	   insights	   into	   the	  behaviour	  of	  enzymes.	  Future	  studies	  should	  strongly	  consider	  this	  approach	  when	  exploring	  enzymes.	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6.1	  Future	  Work	  While	   many	   insights	   were	   gained	   for	   both	   β-­‐lactamase	   and	   glucosamine-­‐6-­‐phosphate	  synthase,	  the	  formation	  of	  the	  last	  intermediate	  step	  for	  the	  β-­‐lactamase	  study	   requires	   more	   investigation.	   Particular	   insights	   were	   gained	   on	   the	  consequences	   of	   the	   S130G	   mutant	   and	   the	   various	   protonation	   states;	   the	  dissociation	  of	  the	  amine	  bond	  has	  yet	  to	  be	  determined.	  The	   bridged	   intermediate	   has	   a	   double	   bond	   between	   the	   bridging	   carbons;	  however	  the	  pathway	  we	  explored	  shows	  no	  double	  bond	  characteristic.1	  Moreover,	  the	  leaving	  nitrogen	  would	  require	  protonation	  in	  order	  to	  be	  a	  better	  leaving	  group.	  This	  would	  also	  lead	  to	  promotion	  of	  Ser130’s	  oxygen	  attacking	  the	  expected	  carbon.	  Herein	   we	   propose	   two	   alternative	   reaction	   schemes,	   which	   may	   lead	   to	   a	  favourable	  pathway	  for	  the	  bridging	  intermediate	  formation	  (Scheme	  6.1).	  	  	  
Scheme	   6.1.	   Proposed	   reaction	   pathway	   of	   cross-­‐linked	   species	   formation	   with	  tazobactam	  with	   (A)	  sulfinate	  acting	  as	   the	  acid/base	  catalyst	  and	  (B)	  carboxylate	  acting	  as	  the	  acid/base	  catalyst.	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Substrate’s	  functional	  groups	  may	  act	  as	  a	  base	  during	  reactions.2	  We	  propose	  a	  similar	  pathway	  for	  the	  formation	  of	  the	  bridging	  intermediate.	  In	  the	  first	  proposed	  mechanism,	   we	   suggest	   that	   a	   carbon	   is	   deprotonated	   by	   the	   nearby	   substrate’s	  carboxylate,	   then	   the	  nitrogen	   is	  protonated	  by	   either	   the	   solvent	   front	  or	  via	   the	  same	  carboxylic	  acid.	  This	  leads	  to	  a	  protonated	  amine	  that	  leads	  to	  Ser130’s	  attack.	  The	   bond	   dissociates	   and	   the	   bridging	   intermediate	   is	   formed.	   Alternatively,	   we	  suggest	   that	   the	  pathway	  may	  proceed	  similarly	  with	  the	  sulfinate	  group	  acting	  as	  the	  base.	  Ultimately,	  both	  pathways	   follow	  similar	  chemistry	  and	   lead	  to	   the	  same	  bridging	  intermediate.	  	  In	   order	   to	   confirm	   that	   these	   are	   viable	   pathways,	   these	   pathways	  must	   be	  explored	  through	  the	  same	  computational	  approaches	  taken	  throughout	  this	  thesis.	  These	   pathways	   would	   hopefully	   lead	   to	   a	   feasible	   pathway	   for	   the	   bridging	  intermediate	  formation.	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